US20070298083A1 - Concentrated omega-3 fatty acids and mixtures containing them - Google Patents
Concentrated omega-3 fatty acids and mixtures containing them Download PDFInfo
- Publication number
- US20070298083A1 US20070298083A1 US11/821,253 US82125307A US2007298083A1 US 20070298083 A1 US20070298083 A1 US 20070298083A1 US 82125307 A US82125307 A US 82125307A US 2007298083 A1 US2007298083 A1 US 2007298083A1
- Authority
- US
- United States
- Prior art keywords
- emulsion
- fatty acids
- esters
- omega
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 145
- 235000020660 omega-3 fatty acid Nutrition 0.000 title claims abstract description 112
- 229940012843 omega-3 fatty acid Drugs 0.000 title claims abstract description 109
- 239000006014 omega-3 oil Substances 0.000 title claims abstract description 73
- 239000000839 emulsion Substances 0.000 claims abstract description 247
- 150000002148 esters Chemical class 0.000 claims abstract description 128
- 235000013361 beverage Nutrition 0.000 claims abstract description 79
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 66
- 235000013305 food Nutrition 0.000 claims abstract description 49
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 36
- 239000003381 stabilizer Substances 0.000 claims abstract description 35
- 239000000654 additive Substances 0.000 claims abstract description 7
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 74
- -1 propylene glycol diesters Chemical class 0.000 claims description 70
- 235000021323 fish oil Nutrition 0.000 claims description 61
- 150000001875 compounds Chemical class 0.000 claims description 60
- 150000004665 fatty acids Chemical class 0.000 claims description 53
- 239000000796 flavoring agent Substances 0.000 claims description 49
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 43
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 41
- 229930195729 fatty acid Natural products 0.000 claims description 41
- 239000000194 fatty acid Substances 0.000 claims description 41
- 235000019634 flavors Nutrition 0.000 claims description 37
- 150000003626 triacylglycerols Chemical class 0.000 claims description 36
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 35
- 239000000787 lecithin Substances 0.000 claims description 25
- 235000010445 lecithin Nutrition 0.000 claims description 25
- 235000013373 food additive Nutrition 0.000 claims description 24
- 239000002778 food additive Substances 0.000 claims description 24
- 108010046377 Whey Proteins Proteins 0.000 claims description 23
- 235000021119 whey protein Nutrition 0.000 claims description 23
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 22
- 239000003963 antioxidant agent Substances 0.000 claims description 22
- 229940067606 lecithin Drugs 0.000 claims description 22
- 102000007544 Whey Proteins Human genes 0.000 claims description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 230000003078 antioxidant effect Effects 0.000 claims description 18
- 125000004185 ester group Chemical group 0.000 claims description 13
- 239000003086 colorant Substances 0.000 claims description 12
- 239000002738 chelating agent Substances 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 239000008122 artificial sweetener Substances 0.000 claims description 8
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 102000011632 Caseins Human genes 0.000 claims description 3
- 108010076119 Caseins Proteins 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 3
- 235000021096 natural sweeteners Nutrition 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 3
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 3
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 3
- 235000002378 plant sterols Nutrition 0.000 claims description 3
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 3
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 229940001941 soy protein Drugs 0.000 claims description 3
- 150000003445 sucroses Chemical class 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical class CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 claims description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 229940023476 agar Drugs 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 239000003613 bile acid Substances 0.000 claims description 2
- 239000003833 bile salt Substances 0.000 claims description 2
- 229940093761 bile salts Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 229940021722 caseins Drugs 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 150000003903 lactic acid esters Chemical class 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 239000003921 oil Substances 0.000 description 80
- 235000019198 oils Nutrition 0.000 description 80
- 235000019645 odor Nutrition 0.000 description 42
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 33
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 33
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 31
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 30
- 239000000047 product Substances 0.000 description 29
- 241000251468 Actinopterygii Species 0.000 description 24
- 235000019688 fish Nutrition 0.000 description 24
- 230000003647 oxidation Effects 0.000 description 23
- 238000007254 oxidation reaction Methods 0.000 description 23
- 235000006708 antioxidants Nutrition 0.000 description 21
- 230000008569 process Effects 0.000 description 21
- 229940013317 fish oils Drugs 0.000 description 18
- 239000000843 powder Substances 0.000 description 17
- 150000001412 amines Chemical class 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 235000008504 concentrate Nutrition 0.000 description 15
- 239000012141 concentrate Substances 0.000 description 15
- 235000010323 ascorbic acid Nutrition 0.000 description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 14
- 239000001301 oxygen Substances 0.000 description 14
- 229910052760 oxygen Inorganic materials 0.000 description 14
- 239000011668 ascorbic acid Substances 0.000 description 13
- 229960005070 ascorbic acid Drugs 0.000 description 13
- 235000015112 vegetable and seed oil Nutrition 0.000 description 13
- 239000008158 vegetable oil Substances 0.000 description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 12
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 12
- 150000003904 phospholipids Chemical class 0.000 description 10
- 235000013355 food flavoring agent Nutrition 0.000 description 9
- 235000003599 food sweetener Nutrition 0.000 description 9
- 239000003765 sweetening agent Substances 0.000 description 9
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 229910021645 metal ion Inorganic materials 0.000 description 7
- 239000007800 oxidant agent Substances 0.000 description 7
- 230000035943 smell Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 6
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- 241001125048 Sardina Species 0.000 description 6
- 206010040904 Skin odour abnormal Diseases 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 6
- 229960005069 calcium Drugs 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 235000001465 calcium Nutrition 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 235000010350 erythorbic acid Nutrition 0.000 description 6
- 150000002576 ketones Chemical class 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 239000004318 erythorbic acid Substances 0.000 description 5
- 229940026239 isoascorbic acid Drugs 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000001630 malic acid Substances 0.000 description 5
- 235000011090 malic acid Nutrition 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 229940087168 alpha tocopherol Drugs 0.000 description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 150000005690 diesters Chemical class 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 230000008786 sensory perception of smell Effects 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 4
- 150000005691 triesters Chemical class 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 239000002076 α-tocopherol Substances 0.000 description 4
- 235000004835 α-tocopherol Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 235000004936 Bromus mango Nutrition 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 241000624562 Cololabis saira Species 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 240000007228 Mangifera indica Species 0.000 description 3
- 235000014826 Mangifera indica Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 241001098054 Pollachius pollachius Species 0.000 description 3
- 241000736084 Scomber japonicus Species 0.000 description 3
- 235000009184 Spondias indica Nutrition 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 3
- 150000004696 coordination complex Chemical class 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 235000021388 linseed oil Nutrition 0.000 description 3
- 239000000944 linseed oil Substances 0.000 description 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000001508 potassium citrate Substances 0.000 description 3
- 229960002635 potassium citrate Drugs 0.000 description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 3
- 235000011082 potassium citrates Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 235000019512 sardine Nutrition 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 3
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 241001454694 Clupeiformes Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000276438 Gadus morhua Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 241000277331 Salmonidae Species 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019513 anchovy Nutrition 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940092124 calcium citrate malate Drugs 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004581 coalescence Methods 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 235000019516 cod Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 238000006392 deoxygenation reaction Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000000426 osmoregulatory effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 235000021085 polyunsaturated fats Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229940124272 protein stabilizer Drugs 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229940014800 succinic anhydride Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 229910001428 transition metal ion Inorganic materials 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 1
- KNIZBZYMVRWQKN-DMTCNVIQSA-N (3s)-3-amino-4-[[(2r)-1-amino-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical class NC(=O)[C@@H](C)NC(=O)[C@@H](N)CC(O)=O KNIZBZYMVRWQKN-DMTCNVIQSA-N 0.000 description 1
- VMQCQYRHANDJBP-IUYQGCFVSA-N (3s)-3-amino-4-[[(2r)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical class OC(=O)C[C@H](N)C(=O)N[C@H](CO)C(N)=O VMQCQYRHANDJBP-IUYQGCFVSA-N 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- 239000001195 (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid Substances 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 241000207934 Eriodictyon Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 235000008690 Pausinystalia yohimbe Nutrition 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000004697 chelate complex Chemical class 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 235000020235 chia seed Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003635 deoxygenating effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229960000673 dextrose monohydrate Drugs 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000021554 flavoured beverage Nutrition 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000010460 hemp oil Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical class Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002496 iodine Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 229940099262 marinol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- FJWLWIRHZOHPIY-UHFFFAOYSA-N potassium;hydroiodide Chemical compound [K].I FJWLWIRHZOHPIY-UHFFFAOYSA-N 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940119224 salmon oil Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229940001607 sodium bisulfite Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229940083599 sodium iodide Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
Definitions
- triglyceride compositions such as aqueous emulsions, made from fish oil, vegetable oil or any other oil containing omega-3 fatty acids.
- the present triglyceride compositions are rich in omega-3 fatty acids and are light colored or colorless and are substantially free of off flavors and objectionable odors. Beverages, food products, and food additives comprising the triglyceride compositions are also disclosed.
- Alpha linolenic acid (C18:3; (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid, “ALA”), eicosapentaenoic acid (C20:5; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid, “EPA”), and docosahexaenoic acid (C22:6; (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid, “DHA”) are long chain polyunsaturated fatty acids having multiple non-conjugated carbon-carbon double bonds with the first of their double bonds at the third carbon from the methyl terminus of the fatty acid and are often collectively referred to as “omega-3 fatty acids” or simply “omega-3s”.
- Other common omega-3 fatty acids include, but
- omega-3 fatty acids are known to have anti-inflammatory functions (enhancing immune response), are effective in the prevention of and therapy for certain thrombotic maladies, for controlling the content of triglycerides in blood in a living system, and for preventing certain thrombotic disturbances (such as, for example, heart attacks, strokes, and the like). Numerous clinical studies have found that omega-3s may further benefit patients with rheumatoid arthritis, high blood pressure, neurodermatitis, and certain other disorders. In response in part to these clinical results, many international institutions and authorities now recommend that individuals increase their daily consumption of omega-3 fatty acids and other polyunsaturated fatty acids (“PUFAs”).
- PUFAs polyunsaturated fatty acids
- Edible oils such as fish oil and vegetable oils
- Triglycerides are esters of glycerol with three long chain carboxylic acids (“fatty acids”).
- fatty acids long chain carboxylic acids
- a portion of the triglycerides in the oil include at least one ester of an omega-3 fatty acid.
- omega-3 fatty acids are consumed from two sources, in the daily diet and/or as dietary supplements.
- the primary source of omega-3 fatty acid in the diet is from fish oil and/or vegetables oils rich in omega-3 fatty acids.
- most people do not consume enough fish and/or vegetables rich in omega-3 fatty acids to achieve the recommended levels of consumption of omega-3s.
- dietary supplements may be necessary for certain people to achieve the health benefits associated with omega-3 fatty acids.
- Fish oils contain varying amounts of omega-3 fatty acids, depending several factors including the type of fish.
- salmon oil may contain EPA at up to 18% by weight of total fatty acid (“TFA”), and DHA at 12% by weight of TFA.
- TFA total fatty acid
- the concentration of desirable omega-3 fatty acids is low in fish oils and the amount of fish oil consumed by an average person through normal diet is typically low.
- the typical total content of EPA and DHA in fish oils is approximately 10-25% by weight of TFA.
- the fish oils containing omega-3 fatty acids can be obtained as by-products in the production of products such as low-fat fish meal and fish cakes and from oil expression by methods such as boiling or expressing methods.
- Omega-3 containing fish oil may be obtained from a variety of fish, such as, but not limited to, sardine and/or pilchard, chub mackerel, pacific saury, Alaskan pollack, cod, anchovies, herring, salmon, tuna, and the like.
- the oil-expressing method employed in obtaining fish oils may be crude and commonly invites lowering of freshness of the material before oil-expression and formation of low-molecular, volatile amines, which are unpleasant smelling substances (e.g. trimethylamine, dimethylamine, and ammonia).
- Trimethylamine (“TMA”) is one of the major volatile amine compounds associated with the typical “fishy” odor. It is produced by an enzymatic conversion of trimethylamine oxide (“TMAO”), which is an osmo-regulatory compound in many marine fish. During the extraction and storage, the generation and mingling of these unpleasant smelling volatile amines in the fish oil cannot be avoided.
- TMAO trimethylamine oxide
- Fish oil also contains amounts of smaller chain length fatty acids, and other highly unsaturated fatty acids in addition to the omega-3s.
- the double bonds in the fatty acid chains of the omega-3s and other PUFAs in fish oils are susceptible to oxidation by oxygen and other oxidizing agents.
- the spoilage of fish oil by oxidation and/or bacterial action during storage may result in low molecular weight acids and low molecular weight compounds, such as ketones and aldehydes, in the oil producing undesirable colors, flavors, and/or odors in the oil.
- TMA low molecular amines
- oxidation products such as ketones and aldehydes
- trimethylamine and other volatile amine compounds have very low odor threshold values (i.e., very low concentrations of TMA and other volatile amines are readily detected by the human sense of smell).
- TMA and other volatile amines are readily detected by the human sense of smell.
- Embodiments of the present disclosure generally relate to aqueous emulsions comprising esters of polyunsaturated fatty acids, compositions comprising the aqueous emulsions, and processes for forming the emulsions.
- the present disclosure provides a stable aqueous emulsion comprising water, an emulsifier, a stabilizer, and a concentrated blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more.
- the esters of fatty acids are esters of polyunsaturated fatty acids, such as omega-3 fatty acids. Beverages, food products, and food additives comprising the aqueous emulsion are also disclosed.
- the present disclosure provides a method of increasing the content of omega-3 fatty acids in a food product.
- the method comprises adding an aqueous emulsion to the food product, wherein the aqueous emulsion comprises water, an emulsifier, a stabilizer, and a concentrated blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more.
- the present disclosure provides a method of providing a food additive having a high concentration of omega-3 fatty acids to a food producer.
- the method comprises mixing water, an emulsifier, a stabilizer, and a concentrated blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more to form a stable aqueous emulsion and providing the stable aqueous emulsion to the food producer.
- the term “comprising” means various components conjointly employed in the preparation of the compositions of the present disclosure. Accordingly, the terms “consisting essentially of” and “consisting of” are embodied in the term “comprising”.
- the term “emulsion” means a stable mixture of two immiscible substances in which one substance, the dispersed phase, is dispersed as tiny droplets within the other substance, the continuous phase.
- fish oil means a triglyceride oil derived from a fish or other marine organism and comprising triglycerides containing at least one ester of an omega-3 fatty acid.
- omega-3 fatty acid means a long chain polyunsaturated fatty acid having a carbon-carbon double bond between the third and fourth carbon from the methyl terminus of the fatty acid chain (i.e., between the omega minus 3 carbon to the omega minus 4 carbon).
- emulsifier means a compound or compounds that aids in the formation of an emulsion.
- stabilizer means a compound or compounds that help stabilize an emulsion by preventing coalescence of the dispersed phase, such as, for example, by Pickering stabilization or other stabilization process.
- the term “triglyceride” means a tri-ester formed from glycerol and three fatty acids. The fatty acids may be the same or different.
- the term “diglyceride” means a di-ester of glycerol and two fatty acids, which may be the same or different. The esters may be formed as a 1,2-diester on the glycerol or a 1,3-diester on the glycerol.
- the term “monoglyceride” means a mono-ester of glycerol (either at the 1-hydroxyl group or the 2-hydroxyl group) and a fatty acid.
- redox potential As used herein, the term “redox potential”, “reduction potential”, or “oxidation-reduction potential” may be used interchangeably and refer to a measurement of the tendency of a compound to gain electrons and thereby be reduced. Reducing the redox potential of a mixture will reduce the likelihood of a compound with a redox potential higher than that of the mixture from becoming oxidized.
- redox modulator means a compound or compounds that may be added to a mixture to change the redox potential of the mixture, for example, increasing the redox potential or decreasing the redox potential of the mixture.
- antioxidant means a compound or compounds that slow or prevent the oxidation of another chemical species, such as an ester of a polyunsaturated fatty acid.
- hydrophilic or “water soluble” when used in reference to an antioxidant means a compound that is highly soluble in water.
- hydrophobic when used in reference to an antioxidant means a compound that is relatively insoluble in water and soluble in a lipid or oil.
- chelator means a compound or ligand that binds or chelates to a metal or metal ion species to form a metal complex or chelate.
- the metal complex or chelate may be less reactive than the non-chelated metal species.
- USRDI The U.S. Recommended Daily Intake
- vitamins and minerals are defined and set forth in the Recommended Daily Dietary Allowance-Food and Nutrition Board, National Academy of Sciences National Research Council, for a serving size of 250 mL of an aqueous composition.
- the present disclosure provides an aqueous emulsion comprising water, an emulsifier, a stabilizer, and a blend of esters comprising esters of polyunsaturated fatty acids.
- the blend of esters may comprise a concentrate, such as concentrated blend described herein, for example, a blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more.
- the emulsions may comprise a beverage or may be added to a beverage. In other embodiments, the emulsions may be added to a food product.
- the emulsion may be a pre-mixed food additive that may be provided to an end user for addition to a food product or beverage. Addition of the emulsion to a food product or beverage may be used to increase the content of the polyunsaturated fatty acid in the food product or beverage.
- Esters of polyunsaturated fatty acids that may be used in various embodiments of the present disclosure include, esters of fatty acids having from 18 to 26 carbon atoms with from 2 to 6 carbon-carbon double bonds. In other embodiments, the esters of fatty acids may have from 20 to 22 carbon atoms with from 2 to 6 carbon-carbon double bonds. The carbon-carbon double bonds will typically have the “cis” or “Z” configuration and in various embodiments, the double bonds will be non-conjugated (i.e., separated by more than one carbon-carbon single bond). In certain specific embodiments, the esters of the fatty acids may be esters of omega-3 fatty acids, such as, but not limited to ALA, EPA, and DHA).
- the esters may be in the form of a blend of esters, such as, for example, a fish oil or vegetable oil comprising triglycerides high in polyunsaturated fatty acids, for example omega-3 fatty acids.
- the fish oil or vegetable oil may be a crude oil, a partially refined oil, a refined oil, or an oil concentrate.
- Suitable fish oils include any marine oil that contains polyunsaturated fatty acids, such as, but not limited to oils derived from sardine, pilchard, chub mackerel, pacific saury, trout, pollack, cod, anchovies, herring, salmon, tuna, and the like.
- Suitable vegetable oils may include flax or linseed oil, hemp oil, soya oil, canola (rapeseed) oil, chia seed oil, pumpkin seed oil, perilla seed oil, purslane, sunflower seed oil, and nuts (walnut, pistachio, peanut, almond, etc., and their respective oils).
- the esters of fatty acids will comprise esters of polyunsaturated fatty acids, such as omega-3 fatty acids.
- the esters of the polyunsaturated fatty acids may include C 1 -C 4 alkyl esters, including ethyl esters and propyl esters, propylene glycol monoesters (i.e., monoesters of 1,2-propanediol), propylene glycol diesters, monoglycerides, diglycerides, triglycerides and combinations of any thereof.
- Esters comprising diglycerides may be 1,2-diglycerides or 1,3-diglycerides and esters comprising monoglycerides may be 1-monoglycerides or 2-monoglycerides.
- esters comprising propylene glycol monoesters the ester functionality may be attached at either the 1-hydroxy group or the 2-hydroxy group.
- ester is a diester or a triester, such as a propylene glycol diester, a diglyceride, or a triglyceride
- at least one of the ester groups is an ester of a polyunsaturated fatty acid, such as an omega-3 fatty acid. That is, one, two, or, in the case of triglycerides, all three of the esters may be ester functional groups of a polyunsaturated fatty acid.
- the other ester(s) of the diester or triester may be a mono- or unsaturated fatty acid.
- the fatty acids forming the esters in the diesters and triesters may be the same or different.
- the esters are triglycerides comprising omega-3 fatty acids, wherein at least one of the ester groups on the triglyceride is an ester of an omega-3 fatty acid.
- the blend of esters comprising esters of polyunsaturated fatty acids may be a concentrated blend of esters of polyunsaturated fatty acids.
- Concentrated blends of esters are blends of esters where the content of the polyunsaturated fatty acid (such as omega-3 fatty acid) has been increased by some refining or treatment process.
- Concentrated blends of esters of polyunsaturated fatty acids may be made by any process known in the art. In specific embodiments, the concentrated blend of esters may be made by the process as described herein.
- the ratio of the different omega-3 fatty acids, such as ALA, EPA, and/or DHA, in the esters of polyunsaturated fatty acids may vary according to the source of the esters or the process through which they are produced.
- different species of fish may have fish oil with differing amounts of the omega-3 fatty acids.
- the diet of the fish or the season of the year may also affect the amount and type of omega-3 fatty acid residues in the fish oil.
- Vegetable oil sources of omega-3 fatty acids may have different types and ratios of the omega-3 fatty acids compared to marine sources.
- the type and ratio of fatty acid residue may also vary.
- the type and ratio of omega-3 fatty acids in the blend may be controlled to give a desired ratio.
- a blend that is high in DHA residues may be desired and thus the production process may be controlled to provide a blend high in DHA.
- a blend with an approximately equal ratio of EPA and DHA or blends with high concentrations of EPA may be produced.
- the ratio of EPA to DHA may be 1.5:1, for example in a blend of esters which comprises about 18% of EPA and 12% DHA.
- the emulsion compositions of the present disclosure should not be limited by the ratio of fatty acid residues in the blend of esters, since different blends of omega-3 esters of fatty acids are contemplated. Specifically, the ratio of the blends of omega-3 fatty acids in the emulsions may depend on the intended final use.
- the concentration of the polyunsaturated fatty acids in the emulsion may be varied according to the amount of the blend of esters dispersed in the water and the concentration of the polyunsaturated fatty acids in the blend of the esters.
- the concentration of the esters of polyunsaturated fatty acid may be measured, for example, as a weight of fatty acids residues per serving size or weight of the emulsion.
- the blend of esters may comprise a blend of esters of omega-3 fatty acids.
- the concentration of omega-3 fatty acid in the emulsion may be from about 100 mg to about 5 g of omega-3 fatty acids per 100 mL of the emulsion.
- the concentration of omega-3 fatty acid in the emulsion may be from about 135 mg to about 4 g.
- the emulsions may comprise differing amounts of the specific omega-3 fatty acid residues.
- the emulsions may comprise from 0 mg to about 2 g of DHA and from 0 mg to about 2 g of EPA per serving.
- the emulsions may comprise at about 150 mg to about 2 g of DHA and about 150 mg to about 2 g of EPA per serving.
- the emulsions may comprise about 250 mg to about 2 g of DHA and about 250 mg to about 2 g of EPA in each serving and in still other embodiments, about 350 mg to about 2 g of DHA and about 350 mg to about 2 g of EPA in each serving.
- the concentration of omega-3 fatty acid in the emulsion may be varied to deliver a desired amount of the omega-3 fatty acid, for example, an amount equivalent to a recommended daily consumption.
- the emulsion may comprise a pH of less than 4.5, such as a pH within a range as disclosed herein.
- the emulsion may comprise a compound capable of reducing the redox potential of the aqueous emulsion. Examples of such compounds are set forth in greater detail herein.
- the aqueous emulsion may comprise at least one of a pH of less than 4.5 and a compound capable of reducing the redox potential of the aqueous emulsion.
- the aqueous emulsions of the present disclosure may further comprise at least one additive selected from the group consisting of an artificial sweetener, a natural sweetener, an artificial flavor, a natural flavor, a redox modulator, an edible acid or acidulant, a preservative, a colorant, and combinations of any thereof.
- at least one additive selected from the group consisting of an artificial sweetener, a natural sweetener, an artificial flavor, a natural flavor, a redox modulator, an edible acid or acidulant, a preservative, a colorant, and combinations of any thereof.
- suitable additives are known in the art or are disclosed in greater detail herein.
- aqueous emulsions may be in the form of a dry powder, which may be produced by drying the emulsion by a suitable method, such as, for example, spray drying, spray congealing, dry blending with carriers such as cyclodextrin, etc.
- the dried emulsion powder may then be reconstituted by adding water to the powder and mixing to rehydrate the powder and reconstitute the emulsion at the desired levels of omega-3 fatty acids in the finished product for intended consumption.
- the aqueous emulsion according to the various embodiments disclosed herein may comprise an emulsifier and a stabilizer.
- the emulsifier may be added to the emulsion to assist in the formation of the emulsion, for example by reducing the surface tension on the surface of the droplets of the lipophilic esters and assisting in the dispersion of the dispersed phase as small droplets in the continuous phase.
- Stabilizers may assist in stabilizing the emulsion by preventing coalescence, flocculation, or creaming of the dispersed phase, such as by creating a repulsive interaction between the droplets of the dispersed phase, for example, by creating an ionic charge on the droplet surface which is repelled by the like charge on the surfaces of the other droplets.
- suitable emulsifiers may include, but are not limited to lecithins, cephalins, plasmalogens, phosphatidyl choline, phosphatidylethanolamine, phosphatidylinositol, cerbroside, sorbitan esters of long chain saturated fatty acids, lactic acid esters of long chain saturated fatty acid monoglycerides, diacetyl tartaric acid esters of long chain saturated fatty acid monoglycerides, monoglycerides, diglycerides, stearoyl lactate, bile salts, bile acids, and combinations of any thereof.
- the emulsifier may be lecithin.
- suitable stabilizers may include proteins, sterols, and gums such as, but are not limited to whey proteins, caseins, soy proteins, animal and plant sterols, sucrose esters of long chain fatty acids, agar, carrageenan, xanthan gum, pectin, guar gum, gum Arabic, gellan gum, sodium carboxymethylcellulose, hydroxypropyl cellulose, locust bean gum, animal and plant sterols (such as, for example, cholesterol, stigmasterol), polyphenols (e.g. green tea extracts), sucrose esters of long chain fatty acids and combinations of any thereof.
- the stabilizer may a whey protein.
- the present disclosure may provide an emulsifier-stabilizer composition for forming a stable aqueous emulsion of a triglyceride oil.
- the triglyceride oil may be a vegetable oil or a fish oil comprising saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, and combinations of any thereof.
- the triglyceride oil may comprise at least one ester group that is an omega-3 fatty acid ester.
- the triglyceride oil is a marine oil, such as a fish oil.
- the emulsifier-stabilizer composition may comprise a phospholipid emulsifier and a protein-based stabilizer.
- the phospholipid emulsifier may be selected from the group consisting of lecithins, cephalins, plasmalogens, phosphatidyl choline, phosphatidylethanolamine, phosphatidylinositol, and combinations of any thereof.
- the phospholipid emulsifier is lecithin.
- the phospholipid emulsifier may be added to the aqueous emulsion in an amount sufficient to make a triglyceride oil to phospholipid emulsifier ratio ranging from about 20 to about 85 parts triglyceride oil to 1 part phospholipid emulsifier.
- the protein-based stabilizer may be selected from the group consisting of a whey protein, a casein, a soy protein, hydrolyzates and partial hydrolyzates thereof, and combinations of any thereof.
- the protein-based stabilizer is a whey protein.
- the protein-based stabilizer may be added to the aqueous emulsion in an amount sufficient to make a triglyceride oil to protein-based stabilizer ratio ranging from about 1 to about 10 parts triglyceride oil to 1 part protein-based stabilizer.
- the phospholipid emulsifier is lecithin and the protein-based stabilizer is a whey protein.
- the lecithin may be added to the emulsion in an amount sufficient to make a triglyceride oil to lecithin ratio ranging from about 20 to about 85 parts triglyceride oil to 1 part lecithin and the whey protein may be added to the emulsion in an amount sufficient to make a triglyceride oil to whey protein ratio ranging from about 1 to about 10 parts triglyceride oil to 1 part whey protein.
- Certain embodiments of the present disclosure provide methods of producing a stable aqueous emulsion of a triglyceride oil, such as the triglyceride oils described herein (including triglycerides having at least one omega-3 fatty acid ester).
- the methods may comprise combining water, the triglyceride oil, and an emulsifier-stabilizer composition to form a mixture, and mixing the mixture to produce the aqueous emulsion.
- the emulsifier-stabilizer composition may be any of the phospholipid emulsifier and protein-based stabilizer compositions described herein.
- the phospholipid emulsifier may be added in an amount as described herein and the protein-based stabilizer may be added to the emulsion in an amount as described herein.
- the phospholipid emulsifier is lecithin.
- the protein-based stabilizer is a whey protein. In one specific embodiment of the method, the emulsifier is lecithin and the stabilizer is a whey protein.
- the method may comprise combining water, the ester of the omega-3 fatty acid, an emulsifier-stabilizer composition comprising a lecithin emulsifier and a whey protein stabilizer to form a mixture and mixing the mixture to produce the aqueous emulsion.
- the lecithin may be added in an amount sufficient to make a ester of an omega-3 fatty acid to lecithin ratio ranging from about 20 to about 85 parts ester of an omega-3 fatty acid to 1 part lecithin and the whey protein may be added in an amount sufficient to make a ester of an omega-3 fatty acid to whey protein ratio ranging from about 1 to about 10 parts ester of an omega-3 fatty acid to 1 part whey protein.
- An edible acid or food grade acid or acidulant can optionally be added to the aqueous emulsions of the present disclosure.
- These acids may be used alone or in combination.
- blends of esters of polyunsaturated fatty acids, such as omega-3 fatty acids, wherein the blend is derived from a marine or fish oil may have an undesirable fishy odor and taste due to the presence of volatile amine compounds.
- Trimethylamine (“TMA”) is one of the major volatile amine compounds associated with the typical “fishy” odor and flavor of fish oils. TMA is produced by an enzymatic conversion of trimethylamine oxide, which is an osmo-regulatory compound in many marine fish. During the extraction, processing, and storage, the generation and mingling of these unpleasant smelling volatile amines in the fish oil cannot be avoided.
- a fishy odor due to the presence of volatile amine compounds, such as TMA, in the headspace above the emulsion may be perceived by the human sense of smell, even at low TMA concentration, such as concentrations above 50 part per billion (ppb), in other cases at concentrations above 1 ppb, and in certain cases at concentration levels above 210 part per trillion (ppt).
- TMA concentration such as concentrations above 50 part per billion (ppb)
- ppb concentrations above 50 part per billion
- concentrations above 1 ppb concentrations above 1 ppb
- ppt concentration levels above 210 part per trillion
- a fishy flavor in the emulsion may be perceived at TMA concentrations of more than 50 ppb, in certain embodiments at concentrations of greater than 1 ppb and in other embodiments at concentrations of greater than 210 ppt based on the total volume of emulsion.
- certain embodiments of the present disclosure provide for an aqueous emulsion, such as described herein, which has no perceptible fish or fishy odor. That is, the emulsion has reduced concentration of volatile amine compounds, such as TMA, both in the oil in the emulsion and in the head space above the emulsion.
- the present disclosure provides for an aqueous emulsion having no perceptible fish odor.
- the aqueous emulsion comprises water and an oil comprising a blend of esters of polyunsaturated fatty acids, such as a blend of triglycerides having at least one omega-3 fatty acid wherein the aqueous emulsion has a pH of less than about 4.5.
- the aqueous emulsion may have a pH ranging from about 2 to about 4. In other embodiments, the aqueous emulsion may have a pH ranging from about 2.5 to about 3.7.
- emulsions having pH's less than 2 are also contemplated and should be considered within the scope of the present disclosure.
- emulsions of lower pH may be utilized and added in amounts such that the pH of the food product comprising the food additive ranges from about 2 to about 4.
- lower pH's may not be optimum and therefore in those applications emulsions having the recited pH ranges may be desired.
- the volatile amines compounds such as TMA, which may be present in a blend of triglycerides, such as a fish oil, within the aqueous emulsions of the present disclosure will be protonated under the acidic conditions associated with the lower pH values described herein. That is, at the pH values recited herein, the volatile amine compounds will be in form of an ammonium salt and not the free amine. It is believed that the increased vapor pressure associated with the ionic ammonium salts will reduce the concentration of the free amine in the head space above the emulsion and therefore reduce the perceived fishy odor.
- free TMA will react with an acidulant under the low pH conditions associated with the emulsion to form an ammonium salt of the (CH 3 ) 3 NH + ion along with the counter ion associated with the conjugate base of the acidulant.
- the compositions in which the free volatile amine compounds are converted to their ammonium salts may have less of a fishy flavor.
- the aqueous emulsions of the present disclosure may comprise a food grade acidulant such as, but not limited to, malic acid, tartaric acid, citric acid, phosphoric acid, acetic acid, lactic acid, fumaric acid, adipic acid, succinic acid, glycono-delta-lactone, succinic anhydride, carbonic acid, and combinations of any thereof.
- the aqueous emulsions of the present disclosure may comprise an acidulant that is a mixture of phosphoric acid and malic acid. The acidulant may be added in sufficient amount necessary to reduce the pH of the aqueous emulsion to the desired pH level, as recited herein. In view of the present disclosure, one skilled in the art could readily determine the amount of acidulant necessary to reduce the pH of the emulsion to the desired levels.
- the aqueous emulsions of the present disclosure may have no perceptible fish taste or odor, for example, by having a reduced concentration of free or undissolved volatile amine compounds, such as free TMA.
- the aqueous emulsion may have a concentration of free or undissolved TMA of less than the detection limit of human taste or sense of smell. That is, a person consuming the emulsion or a composition comprising the emulsion would not taste or smell the TMA.
- the concentration of free or undissolved TMA in the aqueous emulsion may be less than 50 ppb, in certain embodiments less than 1 ppb, and in still other embodiments less than 210 ppt.
- the head space above the aqueous emulsion or a composition that comprises the aqueous emulsion will have a concentration of volatile amine compounds, such as TMA, that is less than the detection limit of the human nose and sense of smell.
- volatile amine compounds such as TMA
- the human nose and smell receptors therein are particularly sensitive to volatile amine compounds, including TMA, such that even small concentrations of the amines can be detected.
- certain volatile amines may be detected even at concentrations as low as about 1 ppb and for certain amines as low as about 210 ppt.
- the detection limit may be as low as about 32 ppt.
- the emulsions of the present disclosure have no perceptible fish odor or odor associated with volatile amine compounds.
- certain embodiments of the aqueous emulsion or compositions that comprise the aqueous emulsion may have a concentration of volatile amine compounds, such as TMA, in the head space above the composition that is less than about 1 ppb.
- the aqueous emulsion may have a head space concentration of volatile amine compounds, such as TMA, of less than about 210 ppt.
- the aqueous emulsion may have a head space concentration of volatile amine compounds, such as TMA, of less than about 32 ppt.
- the present disclosure includes methods of reducing an amount of volatile amine compounds, which may comprise TMA, in an aqueous' emulsion, such as the emulsions of the present disclosure.
- the methods may comprise adding an acidulant to the emulsion in an amount sufficient to decrease the pH of the aqueous emulsion to less than 4.5.
- the acidulant is added in an amount sufficient to decrease the pH to a range of about 2 to about 4 and in other embodiments to a range of about 2.5 to 3.7.
- the aqueous emulsion may comprise an omega-3 fatty acid ester, which in specific embodiments, comprises a triglyceride having at least one omega-3 fatty acid ester and in other embodiments may comprise a fish oil or a concentrate of omega-3 fatty acids (such as the concentrates described herein).
- the acidulants according to certain methods may be selected from the group consisting of malic acid, tartaric acid, citric acid, phosphoric acid, acetic acid, lactic acid, fumaric acid, adipic acid, succinic acid, glycono-delta-lactone, succinic anhydride, carbonic acid, and combinations of any thereof.
- the methods comprise reducing the concentration of volatile amine compound in the head space above the emulsion or a composition comprising the emulsion to a value less than the detection limit of the human nose, such as the volatile amine concentrations described herein.
- inventions of the method may further comprise adding the aqueous emulsion to a beverage or a food product.
- the method may comprise using the aqueous emulsion as a pre-mixed product that may be added to a beverage or food product to increase the amount polyunsaturated fatty acids, such as omega-3 fatty acids, in the beverage or food product.
- the present disclosure provides for an aqueous emulsion comprising water, a blend of esters comprising esters of polyunsaturated fatty acids, and one or more compounds capable of reducing a redox potential of the aqueous emulsion.
- the esters of polyunsaturated fatty acids may be esters of omega-3 fatty acids, such as triglycerides having at least one omega-3 fatty acid ester, for example, a fish oil or a concentrate of omega-3 fatty acid esters.
- the carbon-carbon double bonds of the polyunsaturated fatty acids in the esters of the emulsions may be susceptible to oxidation.
- oxidation of lipids by oxygen may result in decomposition products of the polyunsaturated fatty acid, such as aldehydes and ketones, which can result in undesired off-flavors, colors, or odors in the emulsion.
- singlet oxygen may react directly with a double bond in the fatty acid, or triplet oxygen may react with an activated radical of a fatty acid.
- peroxides may be formed which may then decompose to aldehydes, ketones, and/or other byproducts.
- the resulting emulsion and compositions comprising the emulsion will not have the off-flavors, colors, and odors associated with lipid oxidation and the resulting compositions will demonstrate a higher stability, for example, a longer shelf life.
- a factor in maintaining the stability of the omega-3 fatty acids in the aqueous formulations of the present disclosure is the control of the redox potential of the emulsions or compositions comprising the emulsions. In the presence of water, various food components and compounds may undergo oxidation-reduction reactions, in an equilibrium state that is dictated by the redox potential of the aqueous system.
- the redox potential of the aqueous emulsions or compositions comprising the emulsions is maintained below about 600 mV.
- the redox potential may be maintained below about 500 mV, in other embodiments below 400 mV, in still other embodiments below about 300 mV, in still other embodiments below about 200 mV, and in specific embodiments below about 150 mV.
- One approach to limit oxidation of the fatty acid residues in the emulsions of the present disclosure may be to reduce the redox potential of the aqueous emulsion by the addition of one or more compounds having a redox potential less than the polyunsaturated fatty acid.
- the one or more compounds may be added in an amount sufficient to reduce the redox potential of the compositions to a value such as those described herein.
- the one or more compound having the lower redox potential may stabilize the omega-3 fatty acids by scavenging/reacting with the oxidizing agent before the polyunsaturated fatty acids, and changing the environment from oxidizing into reducing.
- Such omega-3 fatty acid stabilizing aqueous environment may be defined by the following equation: 0 >RP ⁇ ( A ⁇ B *pH)
- the one or more compounds capable of reducing the redox potential of the aqueous emulsion may include, but are not limited to, compounds selected from the group consisting of a compound that lowers the pH of the aqueous emulsion, a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof.
- a compound that lowers the pH of the aqueous emulsion a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof.
- Compounds that lower the pH of the aqueous emulsion are described in greater detail with regards to acidulants.
- the one or more compounds capable of reducing the redox potential of the aqueous emulsion is a redox modulator.
- Redox modulators include compounds that have the property of converting the oxidizing environment of regular water to reducing environment. Normally, the redox modulators have electron donating functional groups. These electron donating compounds keep minerals in a reduced and soluble form, and prevent vitamins and flavors from degradation by reducing the redox potential of the vehicle water.
- Suitable redox modulators may include, but are not limited to, ascorbic acid, ascorbyl palmitate, sodium bisulfite, erythorbic acid, sulfhydryl containing amino acid residues (i.e., amino acids, peptides, and proteins containing the thiol functional group, for example cysteine), polyphenols, flavonoids, soluble dietary fibers (e.g. arabinogalactan), and combinations of any thereof.
- the redox modulator may be one of ascorbic acid, erythorbic acid, and sodium bisulfite.
- the redox modulator may be added in an amount sufficient to reduce the redox potential of the aqueous emulsion to less than 600 mV. In certain embodiments, the redox modulator is added in an amount sufficient to reduce the redox potential to less than 500 mV and in specific embodiments, to less than 400 mV or the other redox potentials as set forth herein.
- the one or more compounds capable of reducing the redox potential of the aqueous emulsion may be a chelator, such as, compounds with two or more electron donating groups, including, but not limited to, ethylenediamine tetraacetic acid (“EDTA”), citric acid, tartaric acid, ascorbic acid, polyphosphates, esters or salts thereof, and combinations of any thereof.
- EDTA ethylenediamine tetraacetic acid
- Chelators are compounds that bind to metal ions to form a metal/chelate complex.
- Metal ions such as certain transition metal ions, may act as oxidizing agents and may oxidize a carbon-carbon double bond in the polyunsaturated fatty acid by abstraction of an H.
- a hydrogen radical i.e., a hydrogen radical
- the peroxy radical may then abstract a H. (hydrogen radical) from another fatty acid chain during a propagation step.
- the chelators described herein may be suitable to chelate to a number of transition metal ions, such as, for example, Fe 2+ , Cu 2+ , Mn 2+ , Co 2+ , Fe 3+ , Mn 2+ , Ni 2+ , and mixtures of any thereof.
- transition metal ions such as, for example, Fe 2+ , Cu 2+ , Mn 2+ , Co 2+ , Fe 3+ , Mn 2+ , Ni 2+ , and mixtures of any thereof.
- Other chelators known to one skilled in the art that may react with these and other metal ions may also be used in certain embodiments of the emulsions.
- the one or more compounds capable of reducing the redox potential of the aqueous emulsion may be a combination of a hydrophilic or water soluble antioxidant and a hydrophobic or oil soluble antioxidant.
- the water soluble antioxidant may be dissolved in the aqueous portion (continuous phase) of the aqueous emulsion whereas the oil soluble antioxidant may be soluble in the dispersed phase of the emulsion (i.e., the oil droplets of the blend of esters comprising esters of polyunsaturated fatty acids).
- Antioxidants typically inhibit oxidation of an oxidation susceptible compound, such as the unsaturated fatty acids, by reacting preferentially with the oxidizing agent before the oxidizing agent reacts with the compound.
- the product of the reaction between the antioxidant and the oxidizing agent is typically inert or non-reactive and should also be tasteless, colorless, and odorless so as not to affect the taste, smell, or look of the product.
- Water soluble antioxidants suitable for use in the various embodiments of the aqueous emulsions include, but are not limited to, ascorbic acid, erythorbic acid, a botanical extract, such as rosemary extract, green tea extract, or other extract containing a polyphenol antioxidant, and combinations thereof.
- Oil soluble antioxidants suitable for use in the various embodiments of the aqueous emulsion include, but are not limited to, vitamin E, tocopherols, ascorbyl palmitate, butylated hydroxyanixole (“BHA”), butylated hydroxytoluene (“BHT”), and combinations of any thereof.
- the water soluble antioxidant and the oil soluble antioxidant may be added to the emulsion in an amount sufficient to inhibit the oxidation of the fatty acid residues.
- the antioxidants may be added in sufficient amount to reduce the redox potential of the emulsion, such as to the levels recited herein.
- the present disclosure also provides methods of reducing oxidation of esters of polyunsaturated fatty acids, such as omega-3 fatty acid esters, in an emulsion.
- the methods comprise adding a compound to an aqueous emulsion comprising water and a blend of esters comprising esters of polyunsaturated fatty acids, wherein the compound is capable of reducing the redox potential of the aqueous emulsion.
- the esters of polyunsaturated fatty acids comprise esters of omega-3 fatty acids, such as triglycerides having at least one omega-3 fatty acid ester.
- esters examples include edible oils containing polyunsaturated fatty acid esters, such as fish oils and certain vegetable oils, as set forth in greater detail herein.
- the compound may be selected from the group consisting of a compound that lowers the pH of the aqueous emulsion, a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof. Examples of such compounds are set forth in greater detail herein.
- the present disclosure provides methods of improving the stability of an aqueous emulsion comprising omega-3 fatty acid esters.
- the methods comprise adding a compound to the aqueous emulsion, wherein the compound is capable of reducing the redox potential of the aqueous emulsions.
- Still other methods of improving the stability of the aqueous emulsion may comprise reducing the redox potential of the aqueous emulsion to a value less than the redox potential of the omega-3 fatty acid esters, such as, less than 600 mV, in certain embodiments less than 500 mV, and in other embodiments less than 400 mV.
- the omega-3 fatty acid esters may be triglycerides comprising at least one ester of an omega-3 fatty acid, including those natural and processed oils set discussed herein.
- the compound may be selected from the group consisting of a compound that lowers the pH of the aqueous emulsion, a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof. Examples of such compounds are set forth in greater detail herein.
- the aqueous emulsion according to any of the various embodiments described herein may be incorporated into a beverage or a food product.
- the present disclosure contemplates a beverage comprising any of the aqueous emulsion described herein. Specific beverages are discussed in greater detail herein.
- the present disclosure contemplates a food product comprising any of the stable aqueous emulsions described herein. Beverages and food products comprising the stable aqueous emulsions described herein may be used, for example, to increase the content of polyunsaturated fatty acids, such as omega-3 fatty acids, in a diet.
- the beverages and food products described herein allow for the ready consumption of polyunsaturated fatty acids and allow a consumer to obtain the benefits associated with a diet high in polyunsaturated fatty acids (such as the omega-3 fatty acids).
- Other embodiments allow for the formation of beverages and food products that contain emulsions wherein the emulsion comprises a blend of omega-3 fatty acid ester derived from a marine or fish oil or a concentrate of omega-3 fatty acid esters (such as described herein).
- such oils typically have an unpleasant fishy odor and flavor due to the presence of volatile amine compounds, such as TMA, and other degradation products from oxidation processes on the fatty acids.
- Such beverages and food products comprising the aqueous emulsions comprising fish oil derived omega-3 fatty acids produced according to the methods recited herein will not have these unpleasant odors and flavors due to the composition and method of production.
- Such aqueous emulsions and beverages and food products formed therefrom will be commercially desirable since many consumers prefer beverages and food products without the off odors and flavors generally associated with fish oils.
- a food additive comprising the aqueous emulsion may include a pre-mixed emulsion that may be provided to an end user food producer who, for example, wants to produce a product that contains increased levels of polyunsaturated fatty acid, such as omega-3 fatty acid, but does not want the product to have undesired odors and/or flavors, such as those associated with free or undissolved volatile amine compounds and/or lipid oxidation products.
- the present disclosure provides methods for increasing the content of polyunsaturated fatty acids, such as, for example, omega-3 fatty acids, in a food product or beverage.
- the methods may comprise adding a stable aqueous emulsion to the food product or beverage, wherein the stable aqueous emulsion comprises water, an emulsifier, a stabilizer, and a blend of esters comprising esters of polyunsaturated fatty acids, such as omega-3 fatty acids.
- the polyunsaturated fatty acid esters may be esters of triglycerides wherein at least one of the ester groups of the triglyceride is an ester of an omega-3 fatty acid, including for example, the concentrate produced by the process disclosed herein.
- the aqueous emulsion may further comprise a lecithin emulsifier and a whey protein stabilizer.
- the aqueous emulsion of the food additive may comprise a redox modulator as set forth in detail herein.
- the food additive may have no perceptible fish odor or flavor.
- the present disclosure provides a food additive comprising the stable aqueous emulsion comprising triglycerides having at least one polyunsaturated fatty acid, such as an omega-3 fatty acid, wherein the food additive has a pH of less than about 4.5 and has no perceptible fishy odor or flavor.
- Other embodiments of the food additive may have a pH ranging from about 2 to about 4 and in certain embodiments from about 2.5 to about 3.7.
- the food additive may have a head space above the food additive with a concentration of volatile amine compounds, such as TMA, that is less than the detection limit of the human nose.
- the volatile amine compound concentration may be less than those limits associated with the aqueous emulsion.
- the stabilized emulsion comprising polyunsaturated fatty acid esters may further comprise one or more compounds capable of reducing the redox potential of the emulsion.
- emulsions comprising the one or more compound will have an environment in which oxidation of the carbon-carbon double bonds of the polyunsaturated fatty acids is inhibited.
- the emulsions and compositions that comprise the emulsions will have lower concentrations of polyunsaturated fatty acid oxidation products, such as certain ketones and aldehydes, and will lack the off flavors and smells associated with a composition comprising the products for oxidized fatty acids.
- inventions of the present disclosure provide a method of providing a food additive having a high concentration of polyunsaturated fatty acids, including omega-3 fatty acids, to a food producer.
- the method comprises mixing water, an emulsifier, a stabilizer, and a blend of esters comprising esters of polyunsaturated fatty acids (such as omega-3 fatty acids, including triglycerides wherein at least one ester is an ester of an omega-3 fatty acid) to form a stable aqueous emulsion and providing the stable aqueous emulsion to a food producer.
- the various embodiments of the stable aqueous emulsion as described by the compositions and methods herein are suitable to be used in these methods.
- the method may further comprise processing and packaging the food additive.
- the present disclosure provides for a beverage comprising the aqueous emulsion, as described herein, wherein the beverage has a pH ranging from about 2 to about 4.
- the beverages of the present disclosure may contain water and omega-3 fatty acids that are stable, bioavailable and without the fishy odor that is associated with the fish oils that contain the omega-3 fatty acids.
- certain embodiments of the beverages may have a head space above the beverage that has a concentration of volatile amine compounds, such as TMA, that is less than the detection limit of the human nose.
- the polyunsaturated fatty acids, including omega-3 fatty acids may come from a variety of sources including vegetable oil, fish oil, or an enriched blend of triglycerides as described herein.
- the beverage comprising the aqueous emulsions described herein may comprise an emulsifier as set forth herein.
- emulsifiers and other optional additives suitable for use in the emulsions and beverages of this disclosure are described in U.S. Pat. Nos. 6,126,980, issued to Smith et al., on Oct. 3, 2000; 5,431,940, issued to Calderas et al., on Jul. 11, 1995; and 6,326,040 B1, issued to Kearney et al., on Dec. 4, 2001.
- the beverages may have about 300 mg of omega-3 fatty acids per each serving, for example a serving from about 50 mL to about 500 mL.
- a “serving” may be as about 250 mL of prepared beverage, however, other serving sizes of the beverage are also contemplated, such as a serving size ranging from about 50 mL to about 1000 mL.
- a “serving” for a powder mix is about 250 mL of liquid after the powder is re-hydrated according to the powder's instructions.
- the beverages may comprise at least about 150 mg of DHA and 150 mg of EPA in each serving.
- the beverage may comprise at least about 250 mg of DHA and 250 mg of EPA in each serving and in still other embodiments the beverage may comprise at least about 350 mg of DHA and 350 mg of EPA in each serving.
- Other ratios of EPA and DHA in each serving of the beverage may include ratios as described in greater detail herein.
- the final beverage product has no perceptible fishy odor or fishy flavor.
- control of pH and/or redox potential of the emulsions, food products, or beverages are important methods for reducing or eliminating the fishy odor and fishy taste and oxidation products in the present compositions, thereby producing stabile compositions.
- Control of the redox potential of the emulsion and compositions comprising the emulsion is discussed in greater detail herein. For example, reducing the redox potential to a value less than 600 mV, and in other embodiments to redox values as recited herein, may result in reduced oxidation of the polyunsaturated fatty acids.
- the beverages may have a pH of less than about 4.5. In certain embodiments, the beverages may have a pH ranging from about 4.0 to about 2.0, and in other embodiments ranging from about 3.7 to about 2.5.
- the beverages have no perceptible fishy odor and/or fishy or off flavor since the resulting beverages will have concentrations of volatile amine compounds, such as TMA, similar to those of the aqueous emulsions that are used to produce the beverage.
- Table 1 illustrates the compositions of certain commercially available fish oils and other natural oils rich in omega-3 fatty acids and suitable for use in the compositions and methods according to various embodiments of the present disclosure.
- the composition and methods of the present disclosure are not intended to be limited to any specific commercial fish oil and may incorporate or use other sources of fish oils, vegetable oils, concentrated or processed oils, and other esters of polyunsaturated fatty acids. Adding these oils to water to form the emulsions as described herein, without further treatment or additives will generally result in an emulsion or composition with a fishy odor and fishy or off flavor, due at least in part to the presence of residual amounts of volatile amines, such as trimethylamine, and other fatty acid oxidation products.
- volatile amines such as trimethylamine, and other fatty acid oxidation products.
- Such an emulsion is generally not suitable to be used as a beverage, food product, or as a food or beverage additive since the fishy odor and/or fishy or off taste is considered unpleasant and is not acceptable to many consumers.
- emulsions according to various embodiments of the present disclosure which can contain blends of esters, such as the fish oils disclosed herein, and have no perceptible smell or off-flavors, present a substantial improvement over the art.
- Fish oils suitable for use as the starting materials in the present disclosure include not only the fat and oils obtained from fish such as described herein, including sardine, pilchard, chub mackerel, pacific saury, salmon, trout, tuna and the like, expressed according to a conventional method, but also fats and oils removed from viscera of pollack, shark, etc. and also from such Mollusca as squid and/or cuttle fish, octopus, etc.
- the fish oil used as the starting material in the present disclosure may be crude fish oil expressed from fish, but in certain embodiments to improve the efficiency of deodorization and molecular distillation in the later stages of processing, it may be desirable to subject the crude fish oil to acid refinement by means of phosphoric acid, sulfuric acid and the like, or to alkali treatment by means of caustic alkali and then further to treatment by preliminary refinement processes, such as deacidification, decoloration, dewaxing, etc., to obtain a product having higher content of triglycerides.
- the crude fish oil may be pre-treated to clean and purify it.
- Those skilled in the art will appreciate that the amount and necessity of pre-processing will depend on the quality of the crude oil stream. Standard cleaning steps known to skilled artisans may be used alone or in combination with other methods. For example, filtration, adsorption, evaporation and steam stripping are all methods that may be used to clean the oil depending on the purity of the crude fish oil.
- the fish oil stream may be optionally filtered to remove solids. The filtered oil may then be fed into an adsorption column to remove certain color and odor bodies.
- the fish oil stream may be optionally treated with steam to strip out certain free fatty acids and other volatile compounds.
- the fish oil is converted to esters of fatty acids via a transesterification reaction.
- the fish oil is treated with an excess of a lower molecular weight alcohol, such as, for example, methanol or ethanol, in the presence of a catalyst.
- a catalyst Any of a variety of common catalysts can be used, such as basic catalysts, for example, sodium methoxide or potassium carbonate.
- Glycerol is the major by-product of the reaction of triglyceride oils with lower alcohols. Most of the glycerol is removed and the esterified oil is then moved to a different vessel.
- the esterified fatty acids may optionally be flashed to remove excess of the lower molecular weight alcohol, which can be recycled if desired.
- the esterified fatty acids may be washed with water to remove water soluble bodies, such as, for example, any remaining glycerol, soap, lower alcohols, odor bodies, color bodies, and/or flavor bodies. The washed, esterified fatty acids are then dried to remove residual water and residual water soluble bodies.
- fractional distillation of the esterified fatty acids removes lower chain length esters and other residual low boilers, for example, certain lower alkyl esters. It is preferred that the C18 and lower esters are removed during distillation to increase the concentration of C20, C22 and longer esterified fatty acids, such as omega-3 fatty acids. While C18, ⁇ -linolenic acid is generally considered one of the beneficial omega-3 fatty acids, in certain embodiments, it is may be removed by distillation in order to increase the concentration of the longer C20 and C22 fatty acid esters, such as esters of EPA and DHA, respectively.
- a wiped film evaporator may be used to further purify the longer chain ester stream by removing some of the high boiling residual compounds. Having removed both high boiling residuals and low boiling residuals, the middle cut of purified and concentrated esters is then moved to a reaction vessel. Excess glycerol is added to this reactor in the presence of a catalyst, for example, a carbonate salt or sodium methoxide to reconvert the fatty acid esters to triglycerides by a second transesterification reaction.
- the concentrated product comprises a blend of triglycerides wherein at least about 50% of the fatty acid residues have a chain length of 20 carbons or more.
- the product may comprise a blend of triglycerides wherein at least 60% of the fatty acid residues have a chain length of 20 carbons or more, in still other embodiments at least 70%, and in still other embodiments at least 80% by weight.
- the desired product has about 90%, by weight, triglycerides having high concentration of long chain polyunsaturated fatty acid residues, including long chain omega-3 fatty acid residues.
- the maximum desired concentration of monoglycerides is about 5% or less, and the maximum desired concentration for diglycerides is about 10% or less.
- the product is purified and further concentrated. It is preferred that the product stream be treated to a water wash, which may be conducted in two stages. Potassium citrate may be added to convert the catalyst to a more easily removed compound, for example, potassium carbonate. In addition, any free fatty acids are converted to soap which are then removed with a water wash. After the water wash, the undesired components may be discarded or recycled and the triglyceride product stream is dried using a conventional dryer.
- a water wash which may be conducted in two stages. Potassium citrate may be added to convert the catalyst to a more easily removed compound, for example, potassium carbonate.
- any free fatty acids are converted to soap which are then removed with a water wash. After the water wash, the undesired components may be discarded or recycled and the triglyceride product stream is dried using a conventional dryer.
- the concentrated triglyceride product stream may be bleached. Bleaching may be carried out in a column with silica gel, bleaching earth, alumina or the like. Certain color bodies, flavor bodies, odor bodies, and oxidized species may be removed by bleaching. The triglyceride product is then moved to an evaporation column where residual mono-esters and any remaining free fatty acids are removed. Optional steam stripping removes residual amounts of the color bodies, flavor bodies, odor bodies, peroxide, if present, and any residual free fatty acids. The cleaning and stripping steps described above may be used individually or in combination to achieve the desired purity for the final product.
- the triglyceride mixture having a high concentration of omega-3 fatty acid esters should be substantially free of odor bodies and have no off flavors.
- the term “substantially free of odor bodies” means that the triglyceride mixture has less than about 50 ppb trimethyl amine.
- the triglyceride mixture may be used in the compositions and methods described herein.
- the aqueous emulsions of the present disclosure may optionally comprise nutrients, such as, vitamins and minerals, for example, but not limited to, calcium, iodine, sodium, potassium, vitamin C, vitamin E, vitamin A, niacin, thiamin, vitamin B 6 , vitamin B 2 , vitamin B 12 , folic acid, selenium, pantothenic acid, and mixtures of any thereof.
- nutrients such as, vitamins and minerals, for example, but not limited to, calcium, iodine, sodium, potassium, vitamin C, vitamin E, vitamin A, niacin, thiamin, vitamin B 6 , vitamin B 2 , vitamin B 12 , folic acid, selenium, pantothenic acid, and mixtures of any thereof.
- a preferred source of calcium may be a calcium citrate malate composition as described in U.S. Pat. Nos. 4,789,510; 4,786,518; and 4,822,847.
- Additional calcium sources suitable for use herein include, for example, calcium citrate, calcium lactate, calcium citrate malate, and amino acid chelated calcium.
- the USRDI for calcium may range from 360 mg per 6 kg for infants to 1200 mg per 54-58 kg female, depending somewhat on age.
- iodine containing salts e.g., sodium iodide, potassium iodide, potassium iodate, sodium iodate, or mixtures, preferably encapsulated potassium iodine.
- the iodine salts may be encapsulated. Iodine may be added up to an amount equal to the current USRDI for iodine of 150 ⁇ g per serving.
- vitamin C ascorbic acid
- vitamin A as retinol (1 mg) or as ⁇ -carotene
- vitamin B 2 1.7 mg
- niacin 20 mg
- thiamin 1.5 mg
- vitamin B 6 2.0 mg
- folic acid 0.4 mg
- vitamin B 12 (6 ⁇ g)
- vitamin E (30 international units).
- the emulsions of the present disclosure may include various vitamins, as described herein, up to concentrations substantially equal to the USRDI amounts.
- Nutritionally supplemental amounts of other vitamins for incorporation into the certain embodiments of the emulsions described herein include, but are not limited to, vitamins B 6 and B 12 , folic acid, niacin, pantothenic acid, folic acid, and vitamins D and E.
- the emulsions according to the various embodiments disclosed herein may also contain nutraceuticals such as glucosamine, phytosterols, chondroitin, soy isoflavones, and phytochemicals, for example bioactives obtained from botanical extracts, such as green tea, grape seeds, curry, ginger, broccoli, raspberry, and the like.
- nutraceuticals such as glucosamine, phytosterols, chondroitin, soy isoflavones, and phytochemicals, for example bioactives obtained from botanical extracts, such as green tea, grape seeds, curry, ginger, broccoli, raspberry, and the like.
- Coloring agent such as the FD&C dyes (e.g. yellow #5, blue #2, red # 40) and/or FD&C Lakes may be optionally added to the emulsions and/or products comprising the emulsions. Such coloring agents may be added to the emulsions for aesthetic reasons only.
- Preferred Lake dyes that can be used in certain embodiments of the present disclosure are the FDA approved Lake dyes, such as Lake red #40, yellow #6, blue #1, and the like. Additionally, a mixture of FD&C dyes and/or a FD&C lake dye in combination with other conventional food and food colorants can be used. The exact amount of coloring agent used will vary, depending on the agents used and the intensity desired in the finished product.
- the coloring agent should be present at a level of from about 0.0001% to about 0.5%, preferably from about 0.004% to about 0.1% by weight of the emulsion or product comprising the emulsion.
- riboflavin can be used as the coloring agent.
- P-carotene and riboflavin may both contribute to color the beverage orange.
- the emulsions and compositions comprising the emulsions of the present disclosure may optionally comprise a flavoring agent consisting of any natural or synthetically prepared fruit or botanical flavorant or flavoring agent or mixtures of botanical flavorant and fruit juice blends.
- a flavoring agent consisting of any natural or synthetically prepared fruit or botanical flavorant or flavoring agent or mixtures of botanical flavorant and fruit juice blends.
- Such flavoring agents are added to the emulsions for aesthetic reasons only, and are not required to mask any fishy odor or off flavor or taste.
- Suitable natural or artificial fruit flavoring agents include, but are not limited to, lemon, orange, grapefruit, strawberry, banana, pear, kiwi, grape, apple, lemon, mango, pineapple, passion fruit, raspberry, and mixtures of any thereof.
- Suitable botanical flavors include, but are not limited to, jamaica, marigold, chrysanthemum, tea, chamomile, ginger, valerian, yohimbe, hops, eriodictyon, ginseng, bilberry, rice, red wine, mango, peony, lemon balm, nut gall, oak chip, lavender, walnut, gentiam, luo han guo, cinnamon, angelica, aloe, agrimony, yarrow, and mixtures of any thereof.
- the flavoring agent may be added in from about 0.01% to about 10% by weight of the emulsion and in another embodiment from about 0.02% to 8% by weight of these flavors can be used.
- dried fruit juices may also be used as flavoring agents.
- the actual amount of flavoring agent will vary and will depend on the type of flavoring agent used and the amount of flavor desired in the finished beverage.
- Other flavor enhancers, as well as flavorants such as chocolate, vanilla, etc., may also be used.
- the emulsions and compositions comprising the emulsions of the present invention may optionally comprise a sweetener or sweetening agent.
- a sweetener or sweetening agent may be added to the emulsions for aesthetic reasons only and are not required to mask any fish odor or off flavor or taste.
- Suitable particulate sugars can be granulated or powdered, and may include sucrose, fructose, dextrose, maltose, lactose, polyols, and mixtures of any thereof.
- the sweetener may be sucrose.
- artificial sweeteners may be utilized in the emulsions.
- pectins and other thickeners may be used with artificial sweeteners, for example, to act as bulking agents and provide texture to the reconstituted dried emulsion.
- artificial sweeteners for example, to act as bulking agents and provide texture to the reconstituted dried emulsion.
- Various mixtures of sugars and artificial sweeteners may also be used.
- Suitable artificial sweeteners include, for example, saccharin, cyclamates, sucralose, acesulfam-K, L-aspartyl-L-phenylalanine lower alkyl ester sweeteners (e.g. aspartame), L-aspartyl-D-alanine amides as disclosed in U.S. Pat. No. 4,411,925 to Brennan et al., L-aspartyl-D-serine amides as disclosed in U.S. Pat. No.
- the emulsions of the present disclosure may be prepared from a variety of water sources, including, for example, deionized water, softened water, water treated by commercially available reverse osmosis processes, and distilled water.
- Water may have high amounts of oxygen dissolved therein, resulting in a high redox potential for the water.
- Certain embodiments of the present disclosure may include treating the water to remove at least a portion of the dissolved oxygen.
- the process includes deoxygenating the water to reduce the concentration of oxygen in the water, or to eliminate all dissolved oxygen.
- the water is stripped of oxygen (and other dissolved gases) by bubbling carbon dioxide or other inert gas, such as nitrogen gas, through the water.
- the dissolved oxygen concentration in the water may also be reduced by heating the water to high temperatures, at which the solubility of the oxygen is reduced.
- the oxygen level in the source water may be reduced to less than 5 parts per million (“ppm”), in other embodiments less than 3 ppm, and in still other embodiments less than 1 ppm.
- the deoxygenation process may also remove other redox potential increasing agents, such as halide gases, for example chlorine gas, as well as volatile organic materials. Additionally, the water may be treated to have a minimal amount of the other electron acceptors that have redox potential greater than the PUFAs, including, for example, ozone, chlorides and hypochlorites, nitrates and nitrites, and metal ions of certain transition metals, such as ions of iron, copper, cobalt, nickel, and manganese.
- halide gases for example chlorine gas
- volatile organic materials volatile organic materials.
- the water may be treated to have a minimal amount of the other electron acceptors that have redox potential greater than the PUFAs, including, for example, ozone, chlorides and hypochlorites, nitrates and nitrites, and metal ions of certain transition metals, such as ions of iron, copper, cobalt, nickel, and manganese.
- the blend of esters comprising esters of polyunsaturated fatty acids, such as a fish oil or enhanced triglyceride blend, is admixed at the desired level, typically under stirring in a high shear mixer, followed by homogenization in an emulsifier. Typically, the admixing step is conducted under an inert gas blanket to exclude outside air and oxygen from the product. Finally, the emulsion may be packaged into glass or plastic bottles, or other suitable container. The plastic material of the bottle may be an oxygen-impermeable barrier and the bottle may be flushed with inert gas, such as nitrogen, prior to filling. Such oxygen-impermeable bottles are commercially available and will be known to those skilled in the art. In other embodiments, the emulsion may be added directly to a food product or a beverage.
- liquid beverage composition according to the present disclosure having the composition set forth in Table 2 is prepared.
- TABLE 2 Composition of Beverage % w/w INGREDIENTS Water 94.927 Phosphoric Acid 0.14 Malic Acid 0.22 Whey Protein 1.33 Potassium citrate 0.1 Dextrose mono hydrate 1.75 Sucrolose 0.02 Sodium EDTA 0.01 FD&C Yellow # 6 0.0012 FD&C Yellow # 5 0.0028 Mango Flavor 0.16 Ascorbic acid 0.024 Lecithin 0.015 Ascorbyl palmitate 0.02 Concentrated Fish Oil (Twin Rivers Tech.
- a liquid beverage composition according to the present disclosure having the composition set forth in Table 3 is prepared.
- TABLE 3 Composition of Beverage % w/w INGREDIENTS Water 57.31 Orange Juice 25.0 Citric Acid 0.37 Sodium Citrate di hydrate 0.17 Sodium EDTA 0.005 Ascorbic Acid 0.08 Acyl Gellan 0.032 High Fructose Corn Syrup 15.5 FD&C Yellow # 6 0.0014 Orange flavor 0.1 Lecithin 0.015 Alpha-tocopherol 0.02 Ropufa ‘30’ Fish Oil (Roche) 1.3 Phytosterol 0.10 Total 100 EPA gm/250 mL 0.4 DHA gm/250 mL 0.3 EPA + DHA g/250 mL 0.7 Omega 3 FA 1.0 Ropufa ‘30’ Fish Oil (Roche) Specification EPA 13.5 DHA 8.0 Omega FA 30.0
- a powder beverage composition according to the present disclosure was prepared.
- the powder can be reconstituted with water to for a drinkable beverage. All the dry ingredients are mixed to get uniform blend.
- the composition of the powder composition is presented in Table 4. TABLE 4 Composition of Beverage Powder % w/w INGREDIENTS Granulated Sugar 71.6 Citric Acid 4.18 Orange powder flavor 1.57 Sodium citrate 2.19 FD&C # 6 Al.
- a ready-to-drink orange colored opaque beverage is prepared by dispersing 45 g of the powder in 1000 mL of water.
- the resulting beverage has a pH of 3.21.
- the resulting beverage contains 390 mg of omega-3 fatty acids per 250 mL serving.
- the beverage has no fishy odor.
- a concentrated fish oil emulsion composition according to the present disclosure is prepared.
- the concentrate emulsion can be diluted with water or other diluent to form a suitable beverage composition, for example, to form a drinkable beverage with desirable amounts of omega-3 fatty acids.
- the concentrated emulsion may also be used as a food additive by adding to a composition to form a food product.
- the composition of the emulsion is presented in Table 5.
- the emulsion has no off odor or fishy odor.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Edible Oils And Fats (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Description
- This application claims the benefit of U.S. Provisional Application No. 60/815,992, filed Jun. 23, 2006.
- This disclosure relates to triglyceride compositions, such as aqueous emulsions, made from fish oil, vegetable oil or any other oil containing omega-3 fatty acids. The present triglyceride compositions are rich in omega-3 fatty acids and are light colored or colorless and are substantially free of off flavors and objectionable odors. Beverages, food products, and food additives comprising the triglyceride compositions are also disclosed.
- Alpha linolenic acid (C18:3; (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid, “ALA”), eicosapentaenoic acid (C20:5; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid, “EPA”), and docosahexaenoic acid (C22:6; (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid, “DHA”) are long chain polyunsaturated fatty acids having multiple non-conjugated carbon-carbon double bonds with the first of their double bonds at the third carbon from the methyl terminus of the fatty acid and are often collectively referred to as “omega-3 fatty acids” or simply “omega-3s”. Other common omega-3 fatty acids include, but are not limited to, stearidonic acid (C18:4), eicosatetraenoic acid (C20:4), and docosapentaenoic acid (C22:5).
- These omega-3 fatty acids are known to have anti-inflammatory functions (enhancing immune response), are effective in the prevention of and therapy for certain thrombotic maladies, for controlling the content of triglycerides in blood in a living system, and for preventing certain thrombotic disturbances (such as, for example, heart attacks, strokes, and the like). Numerous clinical studies have found that omega-3s may further benefit patients with rheumatoid arthritis, high blood pressure, neurodermatitis, and certain other disorders. In response in part to these clinical results, many international institutions and authorities now recommend that individuals increase their daily consumption of omega-3 fatty acids and other polyunsaturated fatty acids (“PUFAs”).
- Edible oils, such as fish oil and vegetable oils, are composed of triglycerides. Triglycerides are esters of glycerol with three long chain carboxylic acids (“fatty acids”). In the omega-3 fish oils and vegetable oils, a portion of the triglycerides in the oil include at least one ester of an omega-3 fatty acid. Typically, omega-3 fatty acids are consumed from two sources, in the daily diet and/or as dietary supplements. The primary source of omega-3 fatty acid in the diet is from fish oil and/or vegetables oils rich in omega-3 fatty acids. However, most people do not consume enough fish and/or vegetables rich in omega-3 fatty acids to achieve the recommended levels of consumption of omega-3s. As such, dietary supplements may be necessary for certain people to achieve the health benefits associated with omega-3 fatty acids.
- Dietary supplements, however, may present their own problems. For example, one of the richest natural sources of omega-3 fatty acids is fish oil, but only a portion of the triglycerides in natural fish oil contain omega-3 fatty acid esters. Thus, supplements containing fish oil will also contain oils of little health benefit value, yet are high in fat and calories. Moreover, fish oil supplements are typically large gelatinized pills that consumers may find difficult to swallow. In addition, once the dietary supplement has dissolved in the stomach, the fish oil may have a negative affect on a person's breath. Further, fish oil is generally not consumed alone or added to foods or beverages in part because of its pungent odor and fishy flavor.
- Fish oils contain varying amounts of omega-3 fatty acids, depending several factors including the type of fish. For example, salmon oil may contain EPA at up to 18% by weight of total fatty acid (“TFA”), and DHA at 12% by weight of TFA. In general, however, the concentration of desirable omega-3 fatty acids is low in fish oils and the amount of fish oil consumed by an average person through normal diet is typically low. While there are natural limits to highly concentrated PUFA triglycerides from fish oils, on account of the triglyceride composition, the typical total content of EPA and DHA in fish oils is approximately 10-25% by weight of TFA.
- The fish oils containing omega-3 fatty acids can be obtained as by-products in the production of products such as low-fat fish meal and fish cakes and from oil expression by methods such as boiling or expressing methods. Omega-3 containing fish oil may be obtained from a variety of fish, such as, but not limited to, sardine and/or pilchard, chub mackerel, pacific saury, Alaskan pollack, cod, anchovies, herring, salmon, tuna, and the like. The oil-expressing method employed in obtaining fish oils may be crude and commonly invites lowering of freshness of the material before oil-expression and formation of low-molecular, volatile amines, which are unpleasant smelling substances (e.g. trimethylamine, dimethylamine, and ammonia). Trimethylamine (“TMA”) is one of the major volatile amine compounds associated with the typical “fishy” odor. It is produced by an enzymatic conversion of trimethylamine oxide (“TMAO”), which is an osmo-regulatory compound in many marine fish. During the extraction and storage, the generation and mingling of these unpleasant smelling volatile amines in the fish oil cannot be avoided.
- Fish oil also contains amounts of smaller chain length fatty acids, and other highly unsaturated fatty acids in addition to the omega-3s. The double bonds in the fatty acid chains of the omega-3s and other PUFAs in fish oils are susceptible to oxidation by oxygen and other oxidizing agents. The spoilage of fish oil by oxidation and/or bacterial action during storage may result in low molecular weight acids and low molecular weight compounds, such as ketones and aldehydes, in the oil producing undesirable colors, flavors, and/or odors in the oil. Therefore, even though fish oil freshly expressed from natural materials may have no perceptible odor, the production of low molecular amines (TMA) and oxidation products, such as ketones and aldehydes, during storage may give the oil an undesired color, flavor, and/or odor, thereby lowering of the commercial value of the fish oil.
- In order to prevent emission of such fish-oil-odors, conventional methods may subject fish oil to refining treatments such as deacidification, deodorization and the like to remove impurities. However, even though conventional refining methods may remove some of the odor causing compound, it may still be impossible to remove completely the volatile amines, aldehydes and ketones since these compounds result from further degradation of the oil or components within the oil upon storage. In addition, there is a tendency in refined or concentrated oils for the emission of fishy odors to become more significant, since the refined fish oil contains higher concentrations of highly unsaturated fatty acids, such as EPA and DHA. Further, trimethylamine and other volatile amine compounds have very low odor threshold values (i.e., very low concentrations of TMA and other volatile amines are readily detected by the human sense of smell). When such oils produced by various commercial methods are incorporated into beverages or food products, the beverages or food products have a noticeable fishy taste and/or smell which many consumers find undesirable.
- As such, there exists a need for an emulsion, beverage, food products, or food additive that contains omega-3 fatty acids and has no perceptible fish smell or taste. Moreover, there exists a need for a method of processing commercially available and relatively inexpensive sources of crude fish and vegetable to produce an enriched and concentrated stream of omega-3 fatty acids that can be used in these beverages, food products, and food additives. These and other advantages over prior compositions and processes are discussed in detail in the present disclosure.
- Embodiments of the present disclosure generally relate to aqueous emulsions comprising esters of polyunsaturated fatty acids, compositions comprising the aqueous emulsions, and processes for forming the emulsions.
- In one embodiment, the present disclosure provides a stable aqueous emulsion comprising water, an emulsifier, a stabilizer, and a concentrated blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more. In certain embodiments the esters of fatty acids are esters of polyunsaturated fatty acids, such as omega-3 fatty acids. Beverages, food products, and food additives comprising the aqueous emulsion are also disclosed.
- In another embodiment, the present disclosure provides a method of increasing the content of omega-3 fatty acids in a food product. The method comprises adding an aqueous emulsion to the food product, wherein the aqueous emulsion comprises water, an emulsifier, a stabilizer, and a concentrated blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more.
- In still other embodiments, the present disclosure provides a method of providing a food additive having a high concentration of omega-3 fatty acids to a food producer. The method comprises mixing water, an emulsifier, a stabilizer, and a concentrated blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more to form a stable aqueous emulsion and providing the stable aqueous emulsion to the food producer.
- Other embodiments of the present disclosure are described in detail in the following specification and claims.
- A. Definitions
- As used herein, the term “comprising” means various components conjointly employed in the preparation of the compositions of the present disclosure. Accordingly, the terms “consisting essentially of” and “consisting of” are embodied in the term “comprising”.
- As used herein, the term “emulsion” means a stable mixture of two immiscible substances in which one substance, the dispersed phase, is dispersed as tiny droplets within the other substance, the continuous phase.
- As used herein, the term “fish oil” means a triglyceride oil derived from a fish or other marine organism and comprising triglycerides containing at least one ester of an omega-3 fatty acid.
- As used herein, the term “omega-3 fatty acid” means a long chain polyunsaturated fatty acid having a carbon-carbon double bond between the third and fourth carbon from the methyl terminus of the fatty acid chain (i.e., between the omega minus 3 carbon to the omega minus 4 carbon).
- As used herein, the term “emulsifier” means a compound or compounds that aids in the formation of an emulsion.
- As used herein, the term “stabilizer” means a compound or compounds that help stabilize an emulsion by preventing coalescence of the dispersed phase, such as, for example, by Pickering stabilization or other stabilization process.
- As used herein, the term “triglyceride” means a tri-ester formed from glycerol and three fatty acids. The fatty acids may be the same or different. As used herein, the term “diglyceride” means a di-ester of glycerol and two fatty acids, which may be the same or different. The esters may be formed as a 1,2-diester on the glycerol or a 1,3-diester on the glycerol. As used herein, the term “monoglyceride” means a mono-ester of glycerol (either at the 1-hydroxyl group or the 2-hydroxyl group) and a fatty acid.
- As used herein, the term “redox potential”, “reduction potential”, or “oxidation-reduction potential” may be used interchangeably and refer to a measurement of the tendency of a compound to gain electrons and thereby be reduced. Reducing the redox potential of a mixture will reduce the likelihood of a compound with a redox potential higher than that of the mixture from becoming oxidized.
- As used herein, the term “redox modulator” means a compound or compounds that may be added to a mixture to change the redox potential of the mixture, for example, increasing the redox potential or decreasing the redox potential of the mixture.
- As used herein, the term “antioxidant” means a compound or compounds that slow or prevent the oxidation of another chemical species, such as an ester of a polyunsaturated fatty acid. As used herein, the terms “hydrophilic” or “water soluble” when used in reference to an antioxidant means a compound that is highly soluble in water. As used herein, the terms “hydrophobic”, “lipophilic”, or “oil soluble”, when used in reference to an antioxidant means a compound that is relatively insoluble in water and soluble in a lipid or oil.
- As used herein the term “chelator” means a compound or ligand that binds or chelates to a metal or metal ion species to form a metal complex or chelate. The metal complex or chelate may be less reactive than the non-chelated metal species.
- As used herein, the terms “per serving”, “per unit serving”, or “serving size” when used in the context of a liquid, such as the emulsions, or beverages herein, refers to a volume of the final emulsion or beverage formulation in milliliters.
- The U.S. Recommended Daily Intake (“USRDI”) for vitamins and minerals are defined and set forth in the Recommended Daily Dietary Allowance-Food and Nutrition Board, National Academy of Sciences National Research Council, for a serving size of 250 mL of an aqueous composition.
- As used herein, all parts, percentages, and ratios are based on weight unless otherwise specified.
- Emulsions
- According to various embodiments, the present disclosure provides an aqueous emulsion comprising water, an emulsifier, a stabilizer, and a blend of esters comprising esters of polyunsaturated fatty acids. In certain embodiments, the blend of esters may comprise a concentrate, such as concentrated blend described herein, for example, a blend of esters comprising greater than 50% of esters of fatty acids having 20 carbons or more. According to certain embodiments, the emulsions may comprise a beverage or may be added to a beverage. In other embodiments, the emulsions may be added to a food product. In still other embodiments, the emulsion may be a pre-mixed food additive that may be provided to an end user for addition to a food product or beverage. Addition of the emulsion to a food product or beverage may be used to increase the content of the polyunsaturated fatty acid in the food product or beverage.
- Esters of polyunsaturated fatty acids that may be used in various embodiments of the present disclosure include, esters of fatty acids having from 18 to 26 carbon atoms with from 2 to 6 carbon-carbon double bonds. In other embodiments, the esters of fatty acids may have from 20 to 22 carbon atoms with from 2 to 6 carbon-carbon double bonds. The carbon-carbon double bonds will typically have the “cis” or “Z” configuration and in various embodiments, the double bonds will be non-conjugated (i.e., separated by more than one carbon-carbon single bond). In certain specific embodiments, the esters of the fatty acids may be esters of omega-3 fatty acids, such as, but not limited to ALA, EPA, and DHA).
- The esters may be in the form of a blend of esters, such as, for example, a fish oil or vegetable oil comprising triglycerides high in polyunsaturated fatty acids, for example omega-3 fatty acids. The fish oil or vegetable oil may be a crude oil, a partially refined oil, a refined oil, or an oil concentrate. Suitable fish oils include any marine oil that contains polyunsaturated fatty acids, such as, but not limited to oils derived from sardine, pilchard, chub mackerel, pacific saury, trout, pollack, cod, anchovies, herring, salmon, tuna, and the like. Suitable vegetable oils may include flax or linseed oil, hemp oil, soya oil, canola (rapeseed) oil, chia seed oil, pumpkin seed oil, perilla seed oil, purslane, sunflower seed oil, and nuts (walnut, pistachio, peanut, almond, etc., and their respective oils).
- The esters of fatty acids will comprise esters of polyunsaturated fatty acids, such as omega-3 fatty acids. According to certain embodiments, the esters of the polyunsaturated fatty acids may include C1-C4 alkyl esters, including ethyl esters and propyl esters, propylene glycol monoesters (i.e., monoesters of 1,2-propanediol), propylene glycol diesters, monoglycerides, diglycerides, triglycerides and combinations of any thereof. Esters comprising diglycerides may be 1,2-diglycerides or 1,3-diglycerides and esters comprising monoglycerides may be 1-monoglycerides or 2-monoglycerides. In esters comprising propylene glycol monoesters, the ester functionality may be attached at either the 1-hydroxy group or the 2-hydroxy group. In those embodiments where ester is a diester or a triester, such as a propylene glycol diester, a diglyceride, or a triglyceride, at least one of the ester groups is an ester of a polyunsaturated fatty acid, such as an omega-3 fatty acid. That is, one, two, or, in the case of triglycerides, all three of the esters may be ester functional groups of a polyunsaturated fatty acid. However, the other ester(s) of the diester or triester may be a mono- or unsaturated fatty acid. Further, the fatty acids forming the esters in the diesters and triesters may be the same or different. In specific embodiments, the esters are triglycerides comprising omega-3 fatty acids, wherein at least one of the ester groups on the triglyceride is an ester of an omega-3 fatty acid.
- According to certain embodiments, the blend of esters comprising esters of polyunsaturated fatty acids may be a concentrated blend of esters of polyunsaturated fatty acids. Concentrated blends of esters are blends of esters where the content of the polyunsaturated fatty acid (such as omega-3 fatty acid) has been increased by some refining or treatment process. Concentrated blends of esters of polyunsaturated fatty acids may be made by any process known in the art. In specific embodiments, the concentrated blend of esters may be made by the process as described herein.
- The ratio of the different omega-3 fatty acids, such as ALA, EPA, and/or DHA, in the esters of polyunsaturated fatty acids may vary according to the source of the esters or the process through which they are produced. For example, different species of fish may have fish oil with differing amounts of the omega-3 fatty acids. In addition, the diet of the fish or the season of the year may also affect the amount and type of omega-3 fatty acid residues in the fish oil. Vegetable oil sources of omega-3 fatty acids may have different types and ratios of the omega-3 fatty acids compared to marine sources. For blends of esters of omega-3 fatty acids that are produced or refined by a chemical or physical process, the type and ratio of fatty acid residue may also vary. For certain processes, the type and ratio of omega-3 fatty acids in the blend may be controlled to give a desired ratio. For example, in certain embodiments a blend that is high in DHA residues may be desired and thus the production process may be controlled to provide a blend high in DHA. In other embodiments, a blend with an approximately equal ratio of EPA and DHA or blends with high concentrations of EPA may be produced. According to one embodiment, the ratio of EPA to DHA may be 1.5:1, for example in a blend of esters which comprises about 18% of EPA and 12% DHA. The emulsion compositions of the present disclosure should not be limited by the ratio of fatty acid residues in the blend of esters, since different blends of omega-3 esters of fatty acids are contemplated. Specifically, the ratio of the blends of omega-3 fatty acids in the emulsions may depend on the intended final use.
- The concentration of the polyunsaturated fatty acids in the emulsion may be varied according to the amount of the blend of esters dispersed in the water and the concentration of the polyunsaturated fatty acids in the blend of the esters. The concentration of the esters of polyunsaturated fatty acid may be measured, for example, as a weight of fatty acids residues per serving size or weight of the emulsion. For example, in certain embodiments, the blend of esters may comprise a blend of esters of omega-3 fatty acids. According to certain embodiments, the concentration of omega-3 fatty acid in the emulsion may be from about 100 mg to about 5 g of omega-3 fatty acids per 100 mL of the emulsion. In other embodiments, the concentration of omega-3 fatty acid in the emulsion may be from about 135 mg to about 4 g. The emulsions may comprise differing amounts of the specific omega-3 fatty acid residues. For example, in certain embodiments, the emulsions may comprise from 0 mg to about 2 g of DHA and from 0 mg to about 2 g of EPA per serving. In certain embodiments, the emulsions may comprise at about 150 mg to about 2 g of DHA and about 150 mg to about 2 g of EPA per serving. In other embodiments, the emulsions may comprise about 250 mg to about 2 g of DHA and about 250 mg to about 2 g of EPA in each serving and in still other embodiments, about 350 mg to about 2 g of DHA and about 350 mg to about 2 g of EPA in each serving. The concentration of omega-3 fatty acid in the emulsion may be varied to deliver a desired amount of the omega-3 fatty acid, for example, an amount equivalent to a recommended daily consumption.
- In certain embodiments the emulsion may comprise a pH of less than 4.5, such as a pH within a range as disclosed herein. In other embodiments, the emulsion may comprise a compound capable of reducing the redox potential of the aqueous emulsion. Examples of such compounds are set forth in greater detail herein. In specific embodiments, the aqueous emulsion may comprise at least one of a pH of less than 4.5 and a compound capable of reducing the redox potential of the aqueous emulsion.
- According to other embodiments, the aqueous emulsions of the present disclosure may further comprise at least one additive selected from the group consisting of an artificial sweetener, a natural sweetener, an artificial flavor, a natural flavor, a redox modulator, an edible acid or acidulant, a preservative, a colorant, and combinations of any thereof. Various suitable additives are known in the art or are disclosed in greater detail herein.
- Other embodiments of the aqueous emulsions may be in the form of a dry powder, which may be produced by drying the emulsion by a suitable method, such as, for example, spray drying, spray congealing, dry blending with carriers such as cyclodextrin, etc. The dried emulsion powder may then be reconstituted by adding water to the powder and mixing to rehydrate the powder and reconstitute the emulsion at the desired levels of omega-3 fatty acids in the finished product for intended consumption.
- Emulsifiers and Stabilizers
- The aqueous emulsion according to the various embodiments disclosed herein may comprise an emulsifier and a stabilizer. The emulsifier may be added to the emulsion to assist in the formation of the emulsion, for example by reducing the surface tension on the surface of the droplets of the lipophilic esters and assisting in the dispersion of the dispersed phase as small droplets in the continuous phase. Stabilizers may assist in stabilizing the emulsion by preventing coalescence, flocculation, or creaming of the dispersed phase, such as by creating a repulsive interaction between the droplets of the dispersed phase, for example, by creating an ionic charge on the droplet surface which is repelled by the like charge on the surfaces of the other droplets.
- According to certain embodiments, suitable emulsifiers may include, but are not limited to lecithins, cephalins, plasmalogens, phosphatidyl choline, phosphatidylethanolamine, phosphatidylinositol, cerbroside, sorbitan esters of long chain saturated fatty acids, lactic acid esters of long chain saturated fatty acid monoglycerides, diacetyl tartaric acid esters of long chain saturated fatty acid monoglycerides, monoglycerides, diglycerides, stearoyl lactate, bile salts, bile acids, and combinations of any thereof. In specific embodiments, the emulsifier may be lecithin.
- According to certain embodiments, suitable stabilizers may include proteins, sterols, and gums such as, but are not limited to whey proteins, caseins, soy proteins, animal and plant sterols, sucrose esters of long chain fatty acids, agar, carrageenan, xanthan gum, pectin, guar gum, gum Arabic, gellan gum, sodium carboxymethylcellulose, hydroxypropyl cellulose, locust bean gum, animal and plant sterols (such as, for example, cholesterol, stigmasterol), polyphenols (e.g. green tea extracts), sucrose esters of long chain fatty acids and combinations of any thereof. In specific embodiments, the stabilizer may a whey protein.
- According to other embodiments, the present disclosure may provide an emulsifier-stabilizer composition for forming a stable aqueous emulsion of a triglyceride oil. The triglyceride oil may be a vegetable oil or a fish oil comprising saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, and combinations of any thereof. In specific embodiments, the triglyceride oil may comprise at least one ester group that is an omega-3 fatty acid ester. In other embodiments, the triglyceride oil is a marine oil, such as a fish oil. The emulsifier-stabilizer composition may comprise a phospholipid emulsifier and a protein-based stabilizer.
- According to various embodiments, the phospholipid emulsifier may be selected from the group consisting of lecithins, cephalins, plasmalogens, phosphatidyl choline, phosphatidylethanolamine, phosphatidylinositol, and combinations of any thereof. In specific embodiments, the phospholipid emulsifier is lecithin. The phospholipid emulsifier may be added to the aqueous emulsion in an amount sufficient to make a triglyceride oil to phospholipid emulsifier ratio ranging from about 20 to about 85 parts triglyceride oil to 1 part phospholipid emulsifier.
- According to certain embodiments, the protein-based stabilizer may be selected from the group consisting of a whey protein, a casein, a soy protein, hydrolyzates and partial hydrolyzates thereof, and combinations of any thereof. In specific embodiments, the protein-based stabilizer is a whey protein. The protein-based stabilizer may be added to the aqueous emulsion in an amount sufficient to make a triglyceride oil to protein-based stabilizer ratio ranging from about 1 to about 10 parts triglyceride oil to 1 part protein-based stabilizer.
- In one specific embodiment, the phospholipid emulsifier is lecithin and the protein-based stabilizer is a whey protein. According to one embodiment, the lecithin may be added to the emulsion in an amount sufficient to make a triglyceride oil to lecithin ratio ranging from about 20 to about 85 parts triglyceride oil to 1 part lecithin and the whey protein may be added to the emulsion in an amount sufficient to make a triglyceride oil to whey protein ratio ranging from about 1 to about 10 parts triglyceride oil to 1 part whey protein.
- Certain embodiments of the present disclosure provide methods of producing a stable aqueous emulsion of a triglyceride oil, such as the triglyceride oils described herein (including triglycerides having at least one omega-3 fatty acid ester). The methods may comprise combining water, the triglyceride oil, and an emulsifier-stabilizer composition to form a mixture, and mixing the mixture to produce the aqueous emulsion. The emulsifier-stabilizer composition may be any of the phospholipid emulsifier and protein-based stabilizer compositions described herein. The phospholipid emulsifier may be added in an amount as described herein and the protein-based stabilizer may be added to the emulsion in an amount as described herein. According to specific embodiments, the phospholipid emulsifier is lecithin. According to other embodiments, the protein-based stabilizer is a whey protein. In one specific embodiment of the method, the emulsifier is lecithin and the stabilizer is a whey protein.
- Other specific embodiments of the present disclosure provide methods of producing a stable aqueous emulsion of an ester of an omega-3 fatty acid. The method may comprise combining water, the ester of the omega-3 fatty acid, an emulsifier-stabilizer composition comprising a lecithin emulsifier and a whey protein stabilizer to form a mixture and mixing the mixture to produce the aqueous emulsion. According to certain embodiments of the method, the lecithin may be added in an amount sufficient to make a ester of an omega-3 fatty acid to lecithin ratio ranging from about 20 to about 85 parts ester of an omega-3 fatty acid to 1 part lecithin and the whey protein may be added in an amount sufficient to make a ester of an omega-3 fatty acid to whey protein ratio ranging from about 1 to about 10 parts ester of an omega-3 fatty acid to 1 part whey protein.
- Acid Component
- An edible acid or food grade acid or acidulant can optionally be added to the aqueous emulsions of the present disclosure. For example, in certain embodiments it may be desirable to regulate the pH of the emulsion. These acids may be used alone or in combination.
- In certain embodiments, blends of esters of polyunsaturated fatty acids, such as omega-3 fatty acids, wherein the blend is derived from a marine or fish oil may have an undesirable fishy odor and taste due to the presence of volatile amine compounds. Trimethylamine (“TMA”) is one of the major volatile amine compounds associated with the typical “fishy” odor and flavor of fish oils. TMA is produced by an enzymatic conversion of trimethylamine oxide, which is an osmo-regulatory compound in many marine fish. During the extraction, processing, and storage, the generation and mingling of these unpleasant smelling volatile amines in the fish oil cannot be avoided. When producing an emulsion of esters of polyunsaturated fatty acids derived from fish oil, a fishy odor due to the presence of volatile amine compounds, such as TMA, in the headspace above the emulsion may be perceived by the human sense of smell, even at low TMA concentration, such as concentrations above 50 part per billion (ppb), in other cases at concentrations above 1 ppb, and in certain cases at concentration levels above 210 part per trillion (ppt). The presence of the volatile amines, such as TMA, in the oil may also result in a fishy flavor associated with an emulsion that comprises the oil. For example, a fishy flavor in the emulsion may be perceived at TMA concentrations of more than 50 ppb, in certain embodiments at concentrations of greater than 1 ppb and in other embodiments at concentrations of greater than 210 ppt based on the total volume of emulsion. Thus, certain embodiments of the present disclosure provide for an aqueous emulsion, such as described herein, which has no perceptible fish or fishy odor. That is, the emulsion has reduced concentration of volatile amine compounds, such as TMA, both in the oil in the emulsion and in the head space above the emulsion.
- In one embodiment, the present disclosure provides for an aqueous emulsion having no perceptible fish odor. The aqueous emulsion comprises water and an oil comprising a blend of esters of polyunsaturated fatty acids, such as a blend of triglycerides having at least one omega-3 fatty acid wherein the aqueous emulsion has a pH of less than about 4.5. In certain embodiments, the aqueous emulsion may have a pH ranging from about 2 to about 4. In other embodiments, the aqueous emulsion may have a pH ranging from about 2.5 to about 3.7. While certain embodiments may have a lower pH limit of about 2, emulsions having pH's less than 2 are also contemplated and should be considered within the scope of the present disclosure. For example, in embodiments wherein the aqueous emulsions comprise a food additive that may be added to a food product, emulsions of lower pH may be utilized and added in amounts such that the pH of the food product comprising the food additive ranges from about 2 to about 4. However, in certain applications, such as those involving food products or beverages, lower pH's may not be optimum and therefore in those applications emulsions having the recited pH ranges may be desired.
- Without intending to be limited by any explanation, it is believed that the volatile amines compounds, such as TMA, which may be present in a blend of triglycerides, such as a fish oil, within the aqueous emulsions of the present disclosure will be protonated under the acidic conditions associated with the lower pH values described herein. That is, at the pH values recited herein, the volatile amine compounds will be in form of an ammonium salt and not the free amine. It is believed that the increased vapor pressure associated with the ionic ammonium salts will reduce the concentration of the free amine in the head space above the emulsion and therefore reduce the perceived fishy odor. For example, free TMA will react with an acidulant under the low pH conditions associated with the emulsion to form an ammonium salt of the (CH3)3NH+ ion along with the counter ion associated with the conjugate base of the acidulant. In addition, the compositions in which the free volatile amine compounds are converted to their ammonium salts may have less of a fishy flavor.
- According to certain embodiments, the aqueous emulsions of the present disclosure may comprise a food grade acidulant such as, but not limited to, malic acid, tartaric acid, citric acid, phosphoric acid, acetic acid, lactic acid, fumaric acid, adipic acid, succinic acid, glycono-delta-lactone, succinic anhydride, carbonic acid, and combinations of any thereof. In one specific embodiment, the aqueous emulsions of the present disclosure may comprise an acidulant that is a mixture of phosphoric acid and malic acid. The acidulant may be added in sufficient amount necessary to reduce the pH of the aqueous emulsion to the desired pH level, as recited herein. In view of the present disclosure, one skilled in the art could readily determine the amount of acidulant necessary to reduce the pH of the emulsion to the desired levels.
- As recited herein, the aqueous emulsions of the present disclosure may have no perceptible fish taste or odor, for example, by having a reduced concentration of free or undissolved volatile amine compounds, such as free TMA. In certain embodiments, the aqueous emulsion may have a concentration of free or undissolved TMA of less than the detection limit of human taste or sense of smell. That is, a person consuming the emulsion or a composition comprising the emulsion would not taste or smell the TMA. In specific embodiments, the concentration of free or undissolved TMA in the aqueous emulsion may be less than 50 ppb, in certain embodiments less than 1 ppb, and in still other embodiments less than 210 ppt.
- In other embodiments, the head space above the aqueous emulsion or a composition that comprises the aqueous emulsion will have a concentration of volatile amine compounds, such as TMA, that is less than the detection limit of the human nose and sense of smell. The human nose and smell receptors therein are particularly sensitive to volatile amine compounds, including TMA, such that even small concentrations of the amines can be detected. For example, certain volatile amines may be detected even at concentrations as low as about 1 ppb and for certain amines as low as about 210 ppt. For certain amine compounds the detection limit may be as low as about 32 ppt. In various embodiments, the emulsions of the present disclosure have no perceptible fish odor or odor associated with volatile amine compounds. Thus, certain embodiments of the aqueous emulsion or compositions that comprise the aqueous emulsion may have a concentration of volatile amine compounds, such as TMA, in the head space above the composition that is less than about 1 ppb. In certain embodiments, the aqueous emulsion may have a head space concentration of volatile amine compounds, such as TMA, of less than about 210 ppt. In other embodiments, the aqueous emulsion may have a head space concentration of volatile amine compounds, such as TMA, of less than about 32 ppt.
- According to certain embodiments, the present disclosure includes methods of reducing an amount of volatile amine compounds, which may comprise TMA, in an aqueous' emulsion, such as the emulsions of the present disclosure. The methods may comprise adding an acidulant to the emulsion in an amount sufficient to decrease the pH of the aqueous emulsion to less than 4.5. In certain embodiments, the acidulant is added in an amount sufficient to decrease the pH to a range of about 2 to about 4 and in other embodiments to a range of about 2.5 to 3.7. In certain embodiments of the methods, the aqueous emulsion may comprise an omega-3 fatty acid ester, which in specific embodiments, comprises a triglyceride having at least one omega-3 fatty acid ester and in other embodiments may comprise a fish oil or a concentrate of omega-3 fatty acids (such as the concentrates described herein). The acidulants according to certain methods may be selected from the group consisting of malic acid, tartaric acid, citric acid, phosphoric acid, acetic acid, lactic acid, fumaric acid, adipic acid, succinic acid, glycono-delta-lactone, succinic anhydride, carbonic acid, and combinations of any thereof. In certain embodiments, the methods comprise reducing the concentration of volatile amine compound in the head space above the emulsion or a composition comprising the emulsion to a value less than the detection limit of the human nose, such as the volatile amine concentrations described herein.
- Other embodiments of the method may further comprise adding the aqueous emulsion to a beverage or a food product. For example, as described in greater detail elsewhere herein, the method may comprise using the aqueous emulsion as a pre-mixed product that may be added to a beverage or food product to increase the amount polyunsaturated fatty acids, such as omega-3 fatty acids, in the beverage or food product.
- Redox Modulators
- According to certain embodiments, the present disclosure provides for an aqueous emulsion comprising water, a blend of esters comprising esters of polyunsaturated fatty acids, and one or more compounds capable of reducing a redox potential of the aqueous emulsion. The esters of polyunsaturated fatty acids may be esters of omega-3 fatty acids, such as triglycerides having at least one omega-3 fatty acid ester, for example, a fish oil or a concentrate of omega-3 fatty acid esters. The carbon-carbon double bonds of the polyunsaturated fatty acids in the esters of the emulsions may be susceptible to oxidation. For example, oxidation of lipids by oxygen, either in the form of triplet oxygen or singlet oxygen, may result in decomposition products of the polyunsaturated fatty acid, such as aldehydes and ketones, which can result in undesired off-flavors, colors, or odors in the emulsion. For example, singlet oxygen may react directly with a double bond in the fatty acid, or triplet oxygen may react with an activated radical of a fatty acid. In either case, peroxides may be formed which may then decompose to aldehydes, ketones, and/or other byproducts. By reducing or inhibiting oxidation of the double bonds in the fatty acids, the resulting emulsion and compositions comprising the emulsion will not have the off-flavors, colors, and odors associated with lipid oxidation and the resulting compositions will demonstrate a higher stability, for example, a longer shelf life.
- Polyunsaturated fatty acids and their esters, such as omega-3 fatty acids, have a redox potential of about 600 mV. That is, the carbon-carbon double bonds in the polyunsaturated fatty acid chain may be oxidized by a compound having a higher redox potential than 600 mV. In certain embodiments, a factor in maintaining the stability of the omega-3 fatty acids in the aqueous formulations of the present disclosure is the control of the redox potential of the emulsions or compositions comprising the emulsions. In the presence of water, various food components and compounds may undergo oxidation-reduction reactions, in an equilibrium state that is dictated by the redox potential of the aqueous system. In the case of omega-3 fatty acids, a redox potential below 600 mV will favor less oxidation of the carbon-carbon double bonds in the fatty acid residue. Thus, in one embodiment, the redox potential of the aqueous emulsions or compositions comprising the emulsions is maintained below about 600 mV. In other embodiments, the redox potential may be maintained below about 500 mV, in other embodiments below 400 mV, in still other embodiments below about 300 mV, in still other embodiments below about 200 mV, and in specific embodiments below about 150 mV.
- One approach to limit oxidation of the fatty acid residues in the emulsions of the present disclosure may be to reduce the redox potential of the aqueous emulsion by the addition of one or more compounds having a redox potential less than the polyunsaturated fatty acid. The one or more compounds may be added in an amount sufficient to reduce the redox potential of the compositions to a value such as those described herein. In this approach, the one or more compound having the lower redox potential may stabilize the omega-3 fatty acids by scavenging/reacting with the oxidizing agent before the polyunsaturated fatty acids, and changing the environment from oxidizing into reducing. Such omega-3 fatty acid stabilizing aqueous environment may be defined by the following equation:
0>RP−(A−B*pH) - Wherein RP, pH are the redox potential (in mV) and pH of the aqueous system. In this equation A is 400 or less and B is 16.
- According to various embodiments, the one or more compounds capable of reducing the redox potential of the aqueous emulsion may include, but are not limited to, compounds selected from the group consisting of a compound that lowers the pH of the aqueous emulsion, a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof. Compounds that lower the pH of the aqueous emulsion are described in greater detail with regards to acidulants.
- One approach to lower the redox potential of the aqueous emulsion comprises adding one or more compounds that lowers the pH of the aqueous emulsion, such as, by adding an acidulant as described herein. In addition to reducing the amount of free or dissolved volatile amine in the composition, adding one or more compounds capable of lowering the pH of the aqueous emulsion will also lower the redox potential of the emulsion thereby reducing the oxidation of the polyunsaturated fatty acid residues within the emulsion. The one or more compounds may be added in an amount sufficient to reduce the pH of the emulsion to the desired levels, such as a pH less than about 4.5, or other level as described herein.
- In certain embodiments, the one or more compounds capable of reducing the redox potential of the aqueous emulsion is a redox modulator. Redox modulators include compounds that have the property of converting the oxidizing environment of regular water to reducing environment. Normally, the redox modulators have electron donating functional groups. These electron donating compounds keep minerals in a reduced and soluble form, and prevent vitamins and flavors from degradation by reducing the redox potential of the vehicle water. Suitable redox modulators may include, but are not limited to, ascorbic acid, ascorbyl palmitate, sodium bisulfite, erythorbic acid, sulfhydryl containing amino acid residues (i.e., amino acids, peptides, and proteins containing the thiol functional group, for example cysteine), polyphenols, flavonoids, soluble dietary fibers (e.g. arabinogalactan), and combinations of any thereof. In specific embodiments, the redox modulator may be one of ascorbic acid, erythorbic acid, and sodium bisulfite. The redox modulator may be added in an amount sufficient to reduce the redox potential of the aqueous emulsion to less than 600 mV. In certain embodiments, the redox modulator is added in an amount sufficient to reduce the redox potential to less than 500 mV and in specific embodiments, to less than 400 mV or the other redox potentials as set forth herein.
- According to other embodiments of the emulsions, the one or more compounds capable of reducing the redox potential of the aqueous emulsion may be a chelator, such as, compounds with two or more electron donating groups, including, but not limited to, ethylenediamine tetraacetic acid (“EDTA”), citric acid, tartaric acid, ascorbic acid, polyphosphates, esters or salts thereof, and combinations of any thereof. Chelators are compounds that bind to metal ions to form a metal/chelate complex. Metal ions, such as certain transition metal ions, may act as oxidizing agents and may oxidize a carbon-carbon double bond in the polyunsaturated fatty acid by abstraction of an H. (i.e., a hydrogen radical) from a methylene alpha to the double bond, resulting in an allylic radical, which may then react with triplet oxygen to form a peroxy radical. The peroxy radical may then abstract a H. (hydrogen radical) from another fatty acid chain during a propagation step. When a chelator chelates to a metal ion in the composition, the metal ion may no longer be able to react with the fatty acid chain, thereby inhibiting the oxidation process. The chelators described herein may be suitable to chelate to a number of transition metal ions, such as, for example, Fe2+, Cu2+, Mn2+, Co2+, Fe3+, Mn2+, Ni2+, and mixtures of any thereof. Other chelators known to one skilled in the art that may react with these and other metal ions may also be used in certain embodiments of the emulsions.
- In still other embodiments, the one or more compounds capable of reducing the redox potential of the aqueous emulsion may be a combination of a hydrophilic or water soluble antioxidant and a hydrophobic or oil soluble antioxidant. According to these embodiments, the water soluble antioxidant may be dissolved in the aqueous portion (continuous phase) of the aqueous emulsion whereas the oil soluble antioxidant may be soluble in the dispersed phase of the emulsion (i.e., the oil droplets of the blend of esters comprising esters of polyunsaturated fatty acids). Antioxidants typically inhibit oxidation of an oxidation susceptible compound, such as the unsaturated fatty acids, by reacting preferentially with the oxidizing agent before the oxidizing agent reacts with the compound. The product of the reaction between the antioxidant and the oxidizing agent is typically inert or non-reactive and should also be tasteless, colorless, and odorless so as not to affect the taste, smell, or look of the product. By utilizing a combination of a water soluble antioxidant and an oil soluble antioxidant in the emulsion, oxidants in either the continuous phase (i.e., the water phase) and the dispersed phase (i.e., the blend of esters) may be neutralized and prevented from reacting with the fatty acid carbon-carbon double bonds. Water soluble antioxidants suitable for use in the various embodiments of the aqueous emulsions include, but are not limited to, ascorbic acid, erythorbic acid, a botanical extract, such as rosemary extract, green tea extract, or other extract containing a polyphenol antioxidant, and combinations thereof. Oil soluble antioxidants suitable for use in the various embodiments of the aqueous emulsion include, but are not limited to, vitamin E, tocopherols, ascorbyl palmitate, butylated hydroxyanixole (“BHA”), butylated hydroxytoluene (“BHT”), and combinations of any thereof. The water soluble antioxidant and the oil soluble antioxidant may be added to the emulsion in an amount sufficient to inhibit the oxidation of the fatty acid residues. For example, the antioxidants may be added in sufficient amount to reduce the redox potential of the emulsion, such as to the levels recited herein.
- According to other embodiments, the present disclosure also provides methods of reducing oxidation of esters of polyunsaturated fatty acids, such as omega-3 fatty acid esters, in an emulsion. The methods comprise adding a compound to an aqueous emulsion comprising water and a blend of esters comprising esters of polyunsaturated fatty acids, wherein the compound is capable of reducing the redox potential of the aqueous emulsion. According to specific embodiments, the esters of polyunsaturated fatty acids comprise esters of omega-3 fatty acids, such as triglycerides having at least one omega-3 fatty acid ester. Examples of such blends of esters include edible oils containing polyunsaturated fatty acid esters, such as fish oils and certain vegetable oils, as set forth in greater detail herein. The compound may be selected from the group consisting of a compound that lowers the pH of the aqueous emulsion, a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof. Examples of such compounds are set forth in greater detail herein.
- According to other embodiments, the present disclosure provides methods of improving the stability of an aqueous emulsion comprising omega-3 fatty acid esters. The methods comprise adding a compound to the aqueous emulsion, wherein the compound is capable of reducing the redox potential of the aqueous emulsions. Still other methods of improving the stability of the aqueous emulsion may comprise reducing the redox potential of the aqueous emulsion to a value less than the redox potential of the omega-3 fatty acid esters, such as, less than 600 mV, in certain embodiments less than 500 mV, and in other embodiments less than 400 mV. The omega-3 fatty acid esters may be triglycerides comprising at least one ester of an omega-3 fatty acid, including those natural and processed oils set discussed herein. The compound may be selected from the group consisting of a compound that lowers the pH of the aqueous emulsion, a redox modulator, a reducing agent, a chelator, an antioxidant, and combinations of any thereof. Examples of such compounds are set forth in greater detail herein.
- Applications
- In certain embodiments, the aqueous emulsion according to any of the various embodiments described herein may be incorporated into a beverage or a food product. For example, according to one embodiment, the present disclosure contemplates a beverage comprising any of the aqueous emulsion described herein. Specific beverages are discussed in greater detail herein. In other embodiments, the present disclosure contemplates a food product comprising any of the stable aqueous emulsions described herein. Beverages and food products comprising the stable aqueous emulsions described herein may be used, for example, to increase the content of polyunsaturated fatty acids, such as omega-3 fatty acids, in a diet. The beverages and food products described herein allow for the ready consumption of polyunsaturated fatty acids and allow a consumer to obtain the benefits associated with a diet high in polyunsaturated fatty acids (such as the omega-3 fatty acids). Other embodiments allow for the formation of beverages and food products that contain emulsions wherein the emulsion comprises a blend of omega-3 fatty acid ester derived from a marine or fish oil or a concentrate of omega-3 fatty acid esters (such as described herein). As discussed in detail herein, such oils typically have an unpleasant fishy odor and flavor due to the presence of volatile amine compounds, such as TMA, and other degradation products from oxidation processes on the fatty acids. However, as set forth herein, such beverages and food products comprising the aqueous emulsions comprising fish oil derived omega-3 fatty acids produced according to the methods recited herein will not have these unpleasant odors and flavors due to the composition and method of production. Such aqueous emulsions and beverages and food products formed therefrom will be commercially desirable since many consumers prefer beverages and food products without the off odors and flavors generally associated with fish oils.
- Other embodiments of the present disclosure provide for a food additive comprising any of the stable aqueous emulsions described herein. A food additive comprising the aqueous emulsion may include a pre-mixed emulsion that may be provided to an end user food producer who, for example, wants to produce a product that contains increased levels of polyunsaturated fatty acid, such as omega-3 fatty acid, but does not want the product to have undesired odors and/or flavors, such as those associated with free or undissolved volatile amine compounds and/or lipid oxidation products. The food additives according to these embodiments may include esters of polyunsaturated fatty acids that are triglycerides having at least one ester group on the triglyceride being an ester of an omega-3 fatty acid, such as a fish or marine oil, a vegetable oil having omega-3 fatty acid esters, or a concentrated oil produced by a process such as those described herein or other known process.
- Thus, according to certain embodiments, the present disclosure provides methods for increasing the content of polyunsaturated fatty acids, such as, for example, omega-3 fatty acids, in a food product or beverage. The methods may comprise adding a stable aqueous emulsion to the food product or beverage, wherein the stable aqueous emulsion comprises water, an emulsifier, a stabilizer, and a blend of esters comprising esters of polyunsaturated fatty acids, such as omega-3 fatty acids. In certain embodiments, the polyunsaturated fatty acid esters may be esters of triglycerides wherein at least one of the ester groups of the triglyceride is an ester of an omega-3 fatty acid, including for example, the concentrate produced by the process disclosed herein. In specific embodiments, the aqueous emulsion may further comprise a lecithin emulsifier and a whey protein stabilizer. According to specific embodiments, the aqueous emulsion of the food additive may comprise a redox modulator as set forth in detail herein.
- In specific embodiments, particularly those comprising polyunsaturated fatty acid esters derived from fish oil, the food additive may have no perceptible fish odor or flavor. According to these embodiments, the present disclosure provides a food additive comprising the stable aqueous emulsion comprising triglycerides having at least one polyunsaturated fatty acid, such as an omega-3 fatty acid, wherein the food additive has a pH of less than about 4.5 and has no perceptible fishy odor or flavor. Other embodiments of the food additive may have a pH ranging from about 2 to about 4 and in certain embodiments from about 2.5 to about 3.7. In a specific embodiment, the food additive may have a head space above the food additive with a concentration of volatile amine compounds, such as TMA, that is less than the detection limit of the human nose. In other embodiments the volatile amine compound concentration may be less than those limits associated with the aqueous emulsion.
- Other embodiments of the stabilized emulsion comprising polyunsaturated fatty acid esters, such as omega-3 fatty acid esters, may further comprise one or more compounds capable of reducing the redox potential of the emulsion. As discussed in detail herein, emulsions comprising the one or more compound will have an environment in which oxidation of the carbon-carbon double bonds of the polyunsaturated fatty acids is inhibited. Thus, the emulsions and compositions that comprise the emulsions will have lower concentrations of polyunsaturated fatty acid oxidation products, such as certain ketones and aldehydes, and will lack the off flavors and smells associated with a composition comprising the products for oxidized fatty acids.
- Other embodiments of the present disclosure provide a method of providing a food additive having a high concentration of polyunsaturated fatty acids, including omega-3 fatty acids, to a food producer. The method comprises mixing water, an emulsifier, a stabilizer, and a blend of esters comprising esters of polyunsaturated fatty acids (such as omega-3 fatty acids, including triglycerides wherein at least one ester is an ester of an omega-3 fatty acid) to form a stable aqueous emulsion and providing the stable aqueous emulsion to a food producer. The various embodiments of the stable aqueous emulsion as described by the compositions and methods herein are suitable to be used in these methods. According to certain embodiments, the method may further comprise processing and packaging the food additive.
- Beverages
- In certain embodiments, the present disclosure provides for a beverage comprising the aqueous emulsion, as described herein, wherein the beverage has a pH ranging from about 2 to about 4. According to certain embodiments, the beverages of the present disclosure may contain water and omega-3 fatty acids that are stable, bioavailable and without the fishy odor that is associated with the fish oils that contain the omega-3 fatty acids. For example, certain embodiments of the beverages may have a head space above the beverage that has a concentration of volatile amine compounds, such as TMA, that is less than the detection limit of the human nose. The polyunsaturated fatty acids, including omega-3 fatty acids, may come from a variety of sources including vegetable oil, fish oil, or an enriched blend of triglycerides as described herein. The beverage comprising the aqueous emulsions described herein may comprise an emulsifier as set forth herein. Other emulsifiers and other optional additives suitable for use in the emulsions and beverages of this disclosure are described in U.S. Pat. Nos. 6,126,980, issued to Smith et al., on Oct. 3, 2000; 5,431,940, issued to Calderas et al., on Jul. 11, 1995; and 6,326,040 B1, issued to Kearney et al., on Dec. 4, 2001.
- In certain embodiments of the present disclosure, the beverages may have about 300 mg of omega-3 fatty acids per each serving, for example a serving from about 50 mL to about 500 mL. As used herein a “serving” may be as about 250 mL of prepared beverage, however, other serving sizes of the beverage are also contemplated, such as a serving size ranging from about 50 mL to about 1000 mL. Thus, a “serving” for a powder mix is about 250 mL of liquid after the powder is re-hydrated according to the powder's instructions. In other embodiments, the beverages may comprise at least about 150 mg of DHA and 150 mg of EPA in each serving. In other embodiments, the beverage may comprise at least about 250 mg of DHA and 250 mg of EPA in each serving and in still other embodiments the beverage may comprise at least about 350 mg of DHA and 350 mg of EPA in each serving. Other ratios of EPA and DHA in each serving of the beverage may include ratios as described in greater detail herein.
- According to the various embodiments, the final beverage product has no perceptible fishy odor or fishy flavor. In certain embodiments, control of pH and/or redox potential of the emulsions, food products, or beverages are important methods for reducing or eliminating the fishy odor and fishy taste and oxidation products in the present compositions, thereby producing stabile compositions. Control of the redox potential of the emulsion and compositions comprising the emulsion is discussed in greater detail herein. For example, reducing the redox potential to a value less than 600 mV, and in other embodiments to redox values as recited herein, may result in reduced oxidation of the polyunsaturated fatty acids. Regulation of the pH of the emulsion and compositions comprising the emulsions is discussed in detail herein. According to certain embodiments, the beverages may have a pH of less than about 4.5. In certain embodiments, the beverages may have a pH ranging from about 4.0 to about 2.0, and in other embodiments ranging from about 3.7 to about 2.5. The beverages have no perceptible fishy odor and/or fishy or off flavor since the resulting beverages will have concentrations of volatile amine compounds, such as TMA, similar to those of the aqueous emulsions that are used to produce the beverage.
- Natural Oils
- Table 1 illustrates the compositions of certain commercially available fish oils and other natural oils rich in omega-3 fatty acids and suitable for use in the compositions and methods according to various embodiments of the present disclosure. The composition and methods of the present disclosure are not intended to be limited to any specific commercial fish oil and may incorporate or use other sources of fish oils, vegetable oils, concentrated or processed oils, and other esters of polyunsaturated fatty acids. Adding these oils to water to form the emulsions as described herein, without further treatment or additives will generally result in an emulsion or composition with a fishy odor and fishy or off flavor, due at least in part to the presence of residual amounts of volatile amines, such as trimethylamine, and other fatty acid oxidation products. Such an emulsion is generally not suitable to be used as a beverage, food product, or as a food or beverage additive since the fishy odor and/or fishy or off taste is considered unpleasant and is not acceptable to many consumers. As such, emulsions according to various embodiments of the present disclosure which can contain blends of esters, such as the fish oils disclosed herein, and have no perceptible smell or off-flavors, present a substantial improvement over the art.
TABLE 1 Examples of Commercially Available Oils Containing Omega-3 Fatty Acids Company Sample % omega-3 % DHA % EPA % ALA Source Blue Pacific Omega-3 10% = 2.2-2.5% 0.7-1.2% 1.2-1.8% Menhaden Antioxidant Blend 20% = 4.4-5.0% 1.1-2.4% 2.4-3.6% fish oil 30% = 6.6-7.5% 2.1-3.6% 3.6-5.4% BASF Dry n-3 18:12 35% 12% 18% fish Dry n-3 5:25C 35% 25% 5% Omega Pure Omega Pure 4.8% fish Lipsome-20 Omega dry 1510 6% 13% Refined oil 20-26% 7-18% 8-18% Martex DHASCO-S 38.3% 1.44% algae Pizzey's Milling BevGrad 30% 22% flaxseed Flaxseed DSM(roche) Ropufa Oil 30% Ropufa powder Loders Marinol Powder 18% 160 mg/g 20 mg/g fish Croklaan Oil 45% 15% 21% B.V.(lipid nutrition) Bioral 6-10% ropufa fish Polar Foods, HiOmega3 70.2% 70.3% Flax oil Inc RegRefin O-3 58.2% 58.2%
Oil Processing - While the present disclosure is explained and exemplified with a blend of esters comprising polyunsaturated fats, concentrates of polyunsaturated fats, such as concentrates made from natural oils (such as marine oils and vegetable oils) may be utilized as the blend of esters. Various commercial processes may be used to produce concentrates suitable for use in the compositions and methods described herein. According to one embodiment, the process as described herein for producing a concentrate high in omega-3 fatty acids from commercially available natural oils may be used. The processing of fish oils, such as using the process as set forth herein, produces blends concentrated in omega-3 fatty acids, however, those skilled in the art will appreciate that the processes described herein can be used with any oil containing PUFAs. Fish oil, however, is an abundant source of PUFAs and omega-3 fatty acids, and may present additional challenges of possessing an undesired odors, undesired tastes, and off colors which may be addressed by the methods disclosed herein.
- Fish oils suitable for use as the starting materials in the present disclosure include not only the fat and oils obtained from fish such as described herein, including sardine, pilchard, chub mackerel, pacific saury, salmon, trout, tuna and the like, expressed according to a conventional method, but also fats and oils removed from viscera of pollack, shark, etc. and also from such Mollusca as squid and/or cuttle fish, octopus, etc.
- The fish oil used as the starting material in the present disclosure may be crude fish oil expressed from fish, but in certain embodiments to improve the efficiency of deodorization and molecular distillation in the later stages of processing, it may be desirable to subject the crude fish oil to acid refinement by means of phosphoric acid, sulfuric acid and the like, or to alkali treatment by means of caustic alkali and then further to treatment by preliminary refinement processes, such as deacidification, decoloration, dewaxing, etc., to obtain a product having higher content of triglycerides.
- The crude fish oil may be pre-treated to clean and purify it. Those skilled in the art will appreciate that the amount and necessity of pre-processing will depend on the quality of the crude oil stream. Standard cleaning steps known to skilled artisans may be used alone or in combination with other methods. For example, filtration, adsorption, evaporation and steam stripping are all methods that may be used to clean the oil depending on the purity of the crude fish oil. In certain cases, the fish oil stream may be optionally filtered to remove solids. The filtered oil may then be fed into an adsorption column to remove certain color and odor bodies. Moreover, the fish oil stream may be optionally treated with steam to strip out certain free fatty acids and other volatile compounds.
- After pre-treating, the fish oil is converted to esters of fatty acids via a transesterification reaction. The fish oil is treated with an excess of a lower molecular weight alcohol, such as, for example, methanol or ethanol, in the presence of a catalyst. Any of a variety of common catalysts can be used, such as basic catalysts, for example, sodium methoxide or potassium carbonate. Glycerol is the major by-product of the reaction of triglyceride oils with lower alcohols. Most of the glycerol is removed and the esterified oil is then moved to a different vessel.
- After the glycerol is removed, the esterified fatty acids may optionally be flashed to remove excess of the lower molecular weight alcohol, which can be recycled if desired. After the optional flashing, the esterified fatty acids may be washed with water to remove water soluble bodies, such as, for example, any remaining glycerol, soap, lower alcohols, odor bodies, color bodies, and/or flavor bodies. The washed, esterified fatty acids are then dried to remove residual water and residual water soluble bodies.
- Next, fractional distillation of the esterified fatty acids removes lower chain length esters and other residual low boilers, for example, certain lower alkyl esters. It is preferred that the C18 and lower esters are removed during distillation to increase the concentration of C20, C22 and longer esterified fatty acids, such as omega-3 fatty acids. While C18, α-linolenic acid is generally considered one of the beneficial omega-3 fatty acids, in certain embodiments, it is may be removed by distillation in order to increase the concentration of the longer C20 and C22 fatty acid esters, such as esters of EPA and DHA, respectively. By targeting the distillation process to extract the longer esterified fatty acids, some of the C18 α-linolenic acid will, of course, be retained, while the overall concentration of omega-3 fatty acids, and specifically, EPA and DHA, will be maximized in the final product.
- Optionally, after distillation, a wiped film evaporator may be used to further purify the longer chain ester stream by removing some of the high boiling residual compounds. Having removed both high boiling residuals and low boiling residuals, the middle cut of purified and concentrated esters is then moved to a reaction vessel. Excess glycerol is added to this reactor in the presence of a catalyst, for example, a carbonate salt or sodium methoxide to reconvert the fatty acid esters to triglycerides by a second transesterification reaction. In certain embodiments, the concentrated product comprises a blend of triglycerides wherein at least about 50% of the fatty acid residues have a chain length of 20 carbons or more. In other embodiments, the product may comprise a blend of triglycerides wherein at least 60% of the fatty acid residues have a chain length of 20 carbons or more, in still other embodiments at least 70%, and in still other embodiments at least 80% by weight. In still other embodiments, the desired product has about 90%, by weight, triglycerides having high concentration of long chain polyunsaturated fatty acid residues, including long chain omega-3 fatty acid residues. The maximum desired concentration of monoglycerides is about 5% or less, and the maximum desired concentration for diglycerides is about 10% or less.
- After the product stream has been converted to triglycerides, the product is purified and further concentrated. It is preferred that the product stream be treated to a water wash, which may be conducted in two stages. Potassium citrate may be added to convert the catalyst to a more easily removed compound, for example, potassium carbonate. In addition, any free fatty acids are converted to soap which are then removed with a water wash. After the water wash, the undesired components may be discarded or recycled and the triglyceride product stream is dried using a conventional dryer.
- Following the removal of moisture, the concentrated triglyceride product stream may be bleached. Bleaching may be carried out in a column with silica gel, bleaching earth, alumina or the like. Certain color bodies, flavor bodies, odor bodies, and oxidized species may be removed by bleaching. The triglyceride product is then moved to an evaporation column where residual mono-esters and any remaining free fatty acids are removed. Optional steam stripping removes residual amounts of the color bodies, flavor bodies, odor bodies, peroxide, if present, and any residual free fatty acids. The cleaning and stripping steps described above may be used individually or in combination to achieve the desired purity for the final product.
- At this stage the triglyceride mixture having a high concentration of omega-3 fatty acid esters should be substantially free of odor bodies and have no off flavors. As used herein, the term “substantially free of odor bodies” means that the triglyceride mixture has less than about 50 ppb trimethyl amine. The triglyceride mixture may be used in the compositions and methods described herein.
- Various embodiments of specific methods for producing the concentrated omega-3 fatty acids are set for in greater detail in U.S. Provisional Application Ser. No. 60/815,991 filed Jun. 23, 2006, and the U.S. Non-Provisional Application entitled “Concentrated and Odorless Omega-3 Fatty Acids”, which claims priority to the above referenced provisional application and is filed on the same date as the present disclosure.
- Nutrients
- The aqueous emulsions of the present disclosure may optionally comprise nutrients, such as, vitamins and minerals, for example, but not limited to, calcium, iodine, sodium, potassium, vitamin C, vitamin E, vitamin A, niacin, thiamin, vitamin B6, vitamin B2, vitamin B12, folic acid, selenium, pantothenic acid, and mixtures of any thereof.
- A preferred source of calcium may be a calcium citrate malate composition as described in U.S. Pat. Nos. 4,789,510; 4,786,518; and 4,822,847. Calcium in the form of calcium phosphate, calcium carbonate, calcium oxide, and calcium hydroxide in micron-sized particles having a dispersed particle size of about 100 nanometers (nm) or less, and in certain compositions, about 80 nm or less, may also be used. Additional calcium sources suitable for use herein include, for example, calcium citrate, calcium lactate, calcium citrate malate, and amino acid chelated calcium. The USRDI for calcium may range from 360 mg per 6 kg for infants to 1200 mg per 54-58 kg female, depending somewhat on age.
- Commercial sources of iodine include iodine containing salts, e.g., sodium iodide, potassium iodide, potassium iodate, sodium iodate, or mixtures, preferably encapsulated potassium iodine. In certain cases, the iodine salts may be encapsulated. Iodine may be added up to an amount equal to the current USRDI for iodine of 150 μg per serving.
- Current USRDI values for various vitamins for healthy adults include: vitamin C (ascorbic acid) (60 mg), vitamin A as retinol (1 mg) or as β-carotene (3 mg), vitamin B2 (1.7 mg), niacin (20 mg), thiamin (1.5 mg), vitamin B6 (2.0 mg), folic acid (0.4 mg), vitamin B12 (6 μg), and vitamin E (30 international units). The emulsions of the present disclosure may include various vitamins, as described herein, up to concentrations substantially equal to the USRDI amounts. Nutritionally supplemental amounts of other vitamins for incorporation into the certain embodiments of the emulsions described herein include, but are not limited to, vitamins B6 and B12, folic acid, niacin, pantothenic acid, folic acid, and vitamins D and E.
- Moreover, the emulsions according to the various embodiments disclosed herein may also contain nutraceuticals such as glucosamine, phytosterols, chondroitin, soy isoflavones, and phytochemicals, for example bioactives obtained from botanical extracts, such as green tea, grape seeds, curry, ginger, broccoli, raspberry, and the like.
- Coloring Agent
- Small amounts of coloring agent, such as the FD&C dyes (e.g. yellow #5, blue #2, red # 40) and/or FD&C Lakes may be optionally added to the emulsions and/or products comprising the emulsions. Such coloring agents may be added to the emulsions for aesthetic reasons only. Preferred Lake dyes that can be used in certain embodiments of the present disclosure are the FDA approved Lake dyes, such as Lake red #40, yellow #6, blue #1, and the like. Additionally, a mixture of FD&C dyes and/or a FD&C lake dye in combination with other conventional food and food colorants can be used. The exact amount of coloring agent used will vary, depending on the agents used and the intensity desired in the finished product. The amount can be readily determined by one skilled in the art. Generally the coloring agent should be present at a level of from about 0.0001% to about 0.5%, preferably from about 0.004% to about 0.1% by weight of the emulsion or product comprising the emulsion. For example, when the emulsion is used in a beverage that is lemon flavored or yellow in color, riboflavin can be used as the coloring agent. For orange flavored beverages, P-carotene and riboflavin may both contribute to color the beverage orange.
- Flavoring Agent
- According to certain embodiments, the emulsions and compositions comprising the emulsions of the present disclosure may optionally comprise a flavoring agent consisting of any natural or synthetically prepared fruit or botanical flavorant or flavoring agent or mixtures of botanical flavorant and fruit juice blends. Such flavoring agents are added to the emulsions for aesthetic reasons only, and are not required to mask any fishy odor or off flavor or taste. Suitable natural or artificial fruit flavoring agents include, but are not limited to, lemon, orange, grapefruit, strawberry, banana, pear, kiwi, grape, apple, lemon, mango, pineapple, passion fruit, raspberry, and mixtures of any thereof. Suitable botanical flavors include, but are not limited to, jamaica, marigold, chrysanthemum, tea, chamomile, ginger, valerian, yohimbe, hops, eriodictyon, ginseng, bilberry, rice, red wine, mango, peony, lemon balm, nut gall, oak chip, lavender, walnut, gentiam, luo han guo, cinnamon, angelica, aloe, agrimony, yarrow, and mixtures of any thereof. For example, in one embodiment the flavoring agent may be added in from about 0.01% to about 10% by weight of the emulsion and in another embodiment from about 0.02% to 8% by weight of these flavors can be used. In other embodiments, dried fruit juices may also be used as flavoring agents. The actual amount of flavoring agent will vary and will depend on the type of flavoring agent used and the amount of flavor desired in the finished beverage. Other flavor enhancers, as well as flavorants such as chocolate, vanilla, etc., may also be used.
- Sweetener
- According to certain embodiments, the emulsions and compositions comprising the emulsions of the present invention may optionally comprise a sweetener or sweetening agent. Such sweetening agents may be added to the emulsions for aesthetic reasons only and are not required to mask any fish odor or off flavor or taste. Suitable particulate sugars can be granulated or powdered, and may include sucrose, fructose, dextrose, maltose, lactose, polyols, and mixtures of any thereof. In one particular embodiment, the sweetener may be sucrose. In other embodiments, artificial sweeteners may be utilized in the emulsions. Often gums, pectins and other thickeners may be used with artificial sweeteners, for example, to act as bulking agents and provide texture to the reconstituted dried emulsion. Various mixtures of sugars and artificial sweeteners may also be used.
- In addition to the particulate sugars described herein, other natural or artificial sweeteners may also be incorporated therein. Suitable artificial sweeteners include, for example, saccharin, cyclamates, sucralose, acesulfam-K, L-aspartyl-L-phenylalanine lower alkyl ester sweeteners (e.g. aspartame), L-aspartyl-D-alanine amides as disclosed in U.S. Pat. No. 4,411,925 to Brennan et al., L-aspartyl-D-serine amides as disclosed in U.S. Pat. No. 4,399,163 to Brennan et al., L-aspartyl-L-1-hydroxymethylalkaneamide sweeteners as disclosed in U.S. Pat. No. 4,338,346 to Brand, L-aspartyl-1-hydroxyethyalkaneamide sweeteners as disclosed in U.S. Pat. No. 4,423,029 to Rizzi, L-aspartyl-D-phenylglycine ester and amide sweeteners as disclosed in European Patent Application 168,112 to J. M. Janusz, published Jan. 15, 1986, and the like. In one specific embodiment the artificial sweetener may be aspartame.
- Preparation of the Emulsion
- The emulsions of the present disclosure may be prepared from a variety of water sources, including, for example, deionized water, softened water, water treated by commercially available reverse osmosis processes, and distilled water.
- Water may have high amounts of oxygen dissolved therein, resulting in a high redox potential for the water. Certain embodiments of the present disclosure may include treating the water to remove at least a portion of the dissolved oxygen. According to one embodiment, the process includes deoxygenating the water to reduce the concentration of oxygen in the water, or to eliminate all dissolved oxygen. According to one method of deoxygenation, the water is stripped of oxygen (and other dissolved gases) by bubbling carbon dioxide or other inert gas, such as nitrogen gas, through the water. The dissolved oxygen concentration in the water may also be reduced by heating the water to high temperatures, at which the solubility of the oxygen is reduced. According to certain embodiments, the oxygen level in the source water may be reduced to less than 5 parts per million (“ppm”), in other embodiments less than 3 ppm, and in still other embodiments less than 1 ppm.
- The deoxygenation process may also remove other redox potential increasing agents, such as halide gases, for example chlorine gas, as well as volatile organic materials. Additionally, the water may be treated to have a minimal amount of the other electron acceptors that have redox potential greater than the PUFAs, including, for example, ozone, chlorides and hypochlorites, nitrates and nitrites, and metal ions of certain transition metals, such as ions of iron, copper, cobalt, nickel, and manganese.
- The blend of esters comprising esters of polyunsaturated fatty acids, such as a fish oil or enhanced triglyceride blend, is admixed at the desired level, typically under stirring in a high shear mixer, followed by homogenization in an emulsifier. Typically, the admixing step is conducted under an inert gas blanket to exclude outside air and oxygen from the product. Finally, the emulsion may be packaged into glass or plastic bottles, or other suitable container. The plastic material of the bottle may be an oxygen-impermeable barrier and the bottle may be flushed with inert gas, such as nitrogen, prior to filling. Such oxygen-impermeable bottles are commercially available and will be known to those skilled in the art. In other embodiments, the emulsion may be added directly to a food product or a beverage.
- The following representative examples are included for purposes of illustration and not limitation.
- In this Example, liquid beverage composition according to the present disclosure having the composition set forth in Table 2 is prepared.
TABLE 2 Composition of Beverage % w/w INGREDIENTS Water 94.927 Phosphoric Acid 0.14 Malic Acid 0.22 Whey Protein 1.33 Potassium citrate 0.1 Dextrose mono hydrate 1.75 Sucrolose 0.02 Sodium EDTA 0.01 FD&C Yellow # 6 0.0012 FD&C Yellow # 5 0.0028 Mango Flavor 0.16 Ascorbic acid 0.024 Lecithin 0.015 Ascorbyl palmitate 0.02 Concentrated Fish Oil (Twin Rivers Tech. Ohio) 0.65 D-Glucosamine hydrochloride 0.63 Total 100 EPA gm/250 mL 0.5 DHA gm/250 mL 0.3 EPA + DHA g/250 mL 0.8 Omega 3 FA 1.0 Conc. Fish Oil specification (Twin Rivers Tech. Ohio) EPA 31.0 DHA 19.5 Omega FA 61.0 - All the water soluble ingredients except for ascorbic acid are dissolved in the given amount of water. Whey protein is added through liquefier and blended to give clear solution. Ascorbic acid is added and dissolved. Separately, ascrobyl palmitate and lecithin are dissolved in fish oil by warming. The oil is then blended with beverage pre-mix by high shear mixer. The beverage is immediately emulsified at 3300 psi pressure, ascetically processed and packed. The resulting emulsion has a pH of 3.34, a specific gravity of 1.018 g/cc, and is physically stable, with no oil or cream separation. The beverage has no off odor or fishy odor.
- In this Example, a liquid beverage composition according to the present disclosure having the composition set forth in Table 3 is prepared.
TABLE 3 Composition of Beverage % w/w INGREDIENTS Water 57.31 Orange Juice 25.0 Citric Acid 0.37 Sodium Citrate di hydrate 0.17 Sodium EDTA 0.005 Ascorbic Acid 0.08 Acyl Gellan 0.032 High Fructose Corn Syrup 15.5 FD&C Yellow # 6 0.0014 Orange flavor 0.1 Lecithin 0.015 Alpha-tocopherol 0.02 Ropufa ‘30’ Fish Oil (Roche) 1.3 Phytosterol 0.10 Total 100 EPA gm/250 mL 0.4 DHA gm/250 mL 0.3 EPA + DHA g/250 mL 0.7 Omega 3 FA 1.0 Ropufa ‘30’ Fish Oil (Roche) Specification EPA 13.5 DHA 8.0 Omega FA 30.0 - All the water soluble ingredients except for ascorbic acid are dissolved in the given amount of water. Whey protein is added through liquefier and blended to give clear solution. Ascorbic acid is added and dissolved. Separately, alpha-tocopherol and lecithin are uniformly dispersed in fish oil. The oil is then blended with beverage pre-mix by high shear mixer. The beverage is immediately emulsified by at 3300 psi pressure, ascetically processed and packed. The resulting emulsion has a pH of 3.25, a specific gravity of 1.031 g/cc, and is physically stable, with no oil or cream separation. The beverage has no off odor or fishy odor.
- In this Example, a powder beverage composition according to the present disclosure was prepared. The powder can be reconstituted with water to for a drinkable beverage. All the dry ingredients are mixed to get uniform blend. The composition of the powder composition is presented in Table 4.
TABLE 4 Composition of Beverage Powder % w/w INGREDIENTS Granulated Sugar 71.6 Citric Acid 4.18 Orange powder flavor 1.57 Sodium citrate 2.19 FD&C # 6 Al. Lake 0.08 FD&C # 5 0.02 Xanthan Gum 0.14 FD&C Yellow # 6 0.00 FD&C Yellow # 5 0.00 Ascorbic acid 0.68 Ropufa‘10’ Powder (Roche) 16.80 Tricalcium phosphate 1.50 Aspartame 1.23 Niacinamide 0.01 Total 100.00 Omega 3 FA mg/250 mL 390 Ropufa ‘10’ Fish Oil (Roche) powder Specification Omega-3 FA NLT 9.0% - A ready-to-drink orange colored opaque beverage is prepared by dispersing 45 g of the powder in 1000 mL of water. The resulting beverage has a pH of 3.21. The resulting beverage contains 390 mg of omega-3 fatty acids per 250 mL serving. The beverage has no fishy odor.
- In this Example, a concentrated fish oil emulsion composition according to the present disclosure is prepared. The concentrate emulsion can be diluted with water or other diluent to form a suitable beverage composition, for example, to form a drinkable beverage with desirable amounts of omega-3 fatty acids. The concentrated emulsion may also be used as a food additive by adding to a composition to form a food product. The composition of the emulsion is presented in Table 5.
- All the water soluble ingredients except for ascorbic acid and erythorbic acid are dissolved in the given amount of water. Whey protein is added through liquefier and blended to give a clear solution. Ascorbic and erythorbic acids are added and dissolved. Separately, alpha-tocopherol, ascorbyl palmitate, and lecithin are uniformly dispersed in fish oil and warmed to dissolve the ascorbyl palmitate. The oil is then blended with the concentrate pre-mix by high shear mixer. The concentrate is immediately emulsified by at 3300 psi pressure, ascetically processed and packed. The resulting concentrated emulsion has a pH of 2.69 and is physically stable, with no oil or cream separation. The emulsion has no off odor or fishy odor.
TABLE 5 Concentrated Emulsion Composition % w/w INGREDIENTS Phosphoric acid 0.7 Malic acid 1.1 Whey protein 0.75 Potassium citrate 0.5 Sodium EDTA 0.05 Lecithin 0.08 Ascorbic acid 0.13 Erythorbic acid 0.25 Ropufa ‘30’ Fish Oil (Roche) 8.25 Ascorbyl palmitate 0.1 Alpha-tocopherol 0.05 Water 85.04 Ropufa ‘30’ Fish Oil (Roche) Specification EPA 13.5 DHA 8.0 Omega FA 30.0 Fish oil Concentrate emulsion contains EPA 1.1 DHA 0.7 Omega FA 2.5 - The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm”.
- All documents cited in the Detailed Description of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
- While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/821,253 US20070298083A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81599206P | 2006-06-23 | 2006-06-23 | |
US11/821,253 US20070298083A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070298083A1 true US20070298083A1 (en) | 2007-12-27 |
Family
ID=38669360
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/821,253 Abandoned US20070298083A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
US11/821,201 Abandoned US20070299133A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
US11/821,226 Abandoned US20070298156A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
US12/651,641 Abandoned US20100104730A1 (en) | 2006-06-23 | 2010-01-04 | Concentrated omega-3 fatty acids and mixtures containing them |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/821,201 Abandoned US20070299133A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
US11/821,226 Abandoned US20070298156A1 (en) | 2006-06-23 | 2007-06-22 | Concentrated omega-3 fatty acids and mixtures containing them |
US12/651,641 Abandoned US20100104730A1 (en) | 2006-06-23 | 2010-01-04 | Concentrated omega-3 fatty acids and mixtures containing them |
Country Status (6)
Country | Link |
---|---|
US (4) | US20070298083A1 (en) |
EP (3) | EP2031982A2 (en) |
CN (3) | CN101478890A (en) |
BR (3) | BRPI0713264A2 (en) |
CA (3) | CA2656028A1 (en) |
WO (3) | WO2007149591A2 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101843571A (en) * | 2010-04-16 | 2010-09-29 | 苏州纳康生物科技有限公司 | Multiple emulsion for loading tea polyphenol and preparation method thereof |
US20120093998A1 (en) * | 2009-02-11 | 2012-04-19 | Karl Manfred Voelker | High concentrated pufa emulsions |
WO2012003515A3 (en) * | 2010-07-02 | 2012-07-05 | Eric Hauser Kuhrts | Stable fatty acid-containing formulations |
US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
US20120269930A1 (en) * | 2009-11-10 | 2012-10-25 | Cognis Ip Management Gmbh | Composition comprising a lipid suitable for human consumption |
US20120308711A1 (en) * | 2010-02-06 | 2012-12-06 | Cognis Ip Management Gmbh | Drink |
WO2013120025A1 (en) | 2012-02-10 | 2013-08-15 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US8722131B2 (en) | 2010-09-07 | 2014-05-13 | Dsm Nutritional Products Ag | Comestible emulsions |
US8741373B2 (en) | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
US8765661B2 (en) | 2008-03-20 | 2014-07-01 | Virun, Inc. | Compositions containing non-polar compounds |
US20150004282A1 (en) * | 2012-01-09 | 2015-01-01 | Pacific Shore Holdings, Inc. | Dietary supplements containing caffeine and niacin |
US9320295B2 (en) | 2010-03-23 | 2016-04-26 | Virun, Inc. | Compositions containing non-polar compounds |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
KR101842988B1 (en) * | 2012-11-02 | 2018-03-28 | 프로노바 바이오파마 노르지 에이에스 | Removal of undesired components from oil compositions |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
US10687547B2 (en) | 2012-02-15 | 2020-06-23 | Kraft Foods Group Brands Llc | Compositions and methods for inhibiting precipitation of dyes in a beverage |
US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
US20210161165A1 (en) * | 2017-09-01 | 2021-06-03 | Fuji Oil Holdings Inc. | Oil and fat composition containing unsaturated fatty acid |
FR3148036A1 (en) * | 2023-04-24 | 2024-10-25 | Polaris | Composition of oil enriched with polyunsaturated fatty acids |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8333994B2 (en) * | 2007-09-17 | 2012-12-18 | The Curators Of The University Of Missouri | Stabilized, biocompatible gold nanoparticles and enviro-friendly method for making same |
US9358310B2 (en) | 2007-09-17 | 2016-06-07 | The Curators Of The University Of Missouri | EGCG stabilized gold nanoparticles and method for making same |
CA2656028A1 (en) * | 2006-06-23 | 2007-12-27 | The Procter & Gamble Company | Concentrated omega-3 fatty acids and mixtures containing them |
US20080058418A1 (en) * | 2006-09-06 | 2008-03-06 | The Coca-Cola Company | Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
US20090018186A1 (en) * | 2006-09-06 | 2009-01-15 | The Coca-Cola Company | Stable beverage products comprising polyunsaturated fatty acid emulsions |
NO327925B1 (en) * | 2007-06-25 | 2009-10-19 | Pharmalogica As | Use of carbonic acid in beverages comprising polyunsaturated fatty acids (PUFA) to prevent oxidation of the fatty acids. |
EP2025248A1 (en) * | 2007-07-31 | 2009-02-18 | Fresenius Kabi Deutschland GmbH | Cachexia prevention supplement |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
US8828472B2 (en) | 2008-02-12 | 2014-09-09 | Ambo Innovations, Llc | Food products containing omega-3 fatty acids |
NO20081487L (en) | 2008-03-27 | 2009-09-28 | Smartfish As | Health promoting drink |
US20100178369A1 (en) * | 2009-01-15 | 2010-07-15 | Nicole Lee Arledge | Antioxidant-stabilized concentrated fish oil |
US8753851B2 (en) * | 2009-04-17 | 2014-06-17 | LiveFuels, Inc. | Systems and methods for culturing algae with bivalves |
DE102009019103A1 (en) * | 2009-04-29 | 2010-11-18 | Mohammad Rahbaran | Beverage, in which pomegranate seed oil (Punica granatum seed oil) is dissolved by a solubilizer or an emulsifier |
US8927043B2 (en) * | 2009-11-10 | 2015-01-06 | Mycell Technologies | Stabilized formulations of fatty acids |
CN101843336A (en) * | 2010-04-22 | 2010-09-29 | 王京南 | Linseed oil fat emulsion oral solution, beverage and manufacturing method thereof |
US9021721B2 (en) * | 2010-05-07 | 2015-05-05 | Ariat International, Inc. | Footwear |
GB201016900D0 (en) * | 2010-10-06 | 2010-11-17 | Probio Asa | Emulsion |
WO2012060861A1 (en) * | 2010-10-25 | 2012-05-10 | Kalamazoo Holdings, Inc. | Simple process to produce and separate water soluble and oil soluble antioxidative flavoring compositions from labiatae herbs using green solvents |
CN102461677B (en) * | 2010-11-19 | 2014-06-18 | 嘉里特种油脂(上海)有限公司 | Composite improving stability of long-chained polyunsaturated fatty acid and application thereof |
DK2654463T3 (en) * | 2010-12-21 | 2018-09-03 | Omegatri As | ANTIOXIDANTS IN FISH OIL POWDER AND TABLETS |
US20120251685A1 (en) * | 2011-04-04 | 2012-10-04 | Martek Biosciences Corporation | Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same |
US9487716B2 (en) | 2011-05-06 | 2016-11-08 | LiveFuels, Inc. | Sourcing phosphorus and other nutrients from the ocean via ocean thermal energy conversion systems |
US20210307349A1 (en) * | 2011-05-12 | 2021-10-07 | Mycell Technologies, Llc | Formulations of phospholipid comprising omega fatty acids |
GB201208910D0 (en) * | 2012-05-21 | 2012-07-04 | Croda Int Plc | Emulsion |
CN103416759A (en) * | 2012-05-24 | 2013-12-04 | 内蒙古蒙牛乳业(集团)股份有限公司 | DHA emulsion, preparation method thereof and applications thereof in UHT liquid milk |
US10130601B2 (en) * | 2013-06-27 | 2018-11-20 | Smartfish As | Use of a composition comprising fish oil and juice for the treatment of inflammation |
CN105960173A (en) * | 2013-12-20 | 2016-09-21 | 雅培公司 | Nutritional composition containing oxidizable oil and rosmarinic acid |
US9717817B2 (en) | 2013-12-30 | 2017-08-01 | International Paper Company | Binary odor control system for absorbent articles |
JP6318114B2 (en) * | 2014-05-07 | 2018-04-25 | 株式会社ヤクルト本社 | Algae-derived ingredients |
CN106687113B (en) | 2014-06-06 | 2021-09-03 | 海洋原料公司 | Omega-3 compositions, dosage forms, and methods of use |
AU2015301478A1 (en) | 2014-08-14 | 2017-03-09 | Change Cola, Inc. | Carbonated drink comprising omega, vitamins and minerals |
US20170245529A1 (en) * | 2014-10-08 | 2017-08-31 | Abbott Laboratories | Nutritional compositions comprising an oxidizable component and water-soluble plant extract |
ES2607715B1 (en) * | 2015-10-01 | 2018-01-17 | Solutex Na, Lcc | PROCESS FOR THE PREPARATION AND STABILIZATION OF EMULSIONS WITH OMEGA-3 THROUGH ISOMETRIC CRYSTAL NETWORKS OF CELLULOSE DERIVATIVES |
MX2018004128A (en) * | 2015-10-05 | 2018-05-17 | Dsm Ip Assets Bv | Oil compositions and methods of making. |
JP6512380B1 (en) * | 2017-10-05 | 2019-05-15 | 不二製油株式会社 | White chocolate-like food containing highly unsaturated fatty acids |
KR102172036B1 (en) * | 2017-11-08 | 2020-10-30 | 주식회사 오스테온 | A fabrication method of composition contained unsaturated oils and arginine for suppressed odor |
WO2019093708A1 (en) * | 2017-11-08 | 2019-05-16 | 김승수 | Method for producing odor-suppressing composition containing unsaturated oil and arginine |
JP6913041B2 (en) * | 2018-02-05 | 2021-08-04 | 日清食品ホールディングス株式会社 | A flavor for Chinese noodles and a method for producing the same, and a Chinese noodle containing the flavor for Chinese noodles and a method for producing the same. |
WO2019226179A1 (en) * | 2018-05-25 | 2019-11-28 | International Paper Company | Odor-control absorbent materials and absorbent articles and related methods of use and methods of making |
US11471555B2 (en) | 2018-05-25 | 2022-10-18 | International Paper Company | Methods of reducing trimethylamine |
CN110100993B (en) * | 2019-05-31 | 2023-03-31 | 上海交通大学 | Emulsion for delaying fish oil oxidation and preparation method thereof |
CN110731911A (en) * | 2019-10-17 | 2020-01-31 | 贝亲母婴用品(上海)有限公司 | composition for increasing water content of stratum corneum |
WO2021224940A1 (en) * | 2020-05-02 | 2021-11-11 | Bioplus Life Sciences Pvt. Ltd. | Omega fatty acids-rich oil dispersion formulations |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338346A (en) * | 1978-12-21 | 1982-07-06 | The Procter & Gamble Company | Non-nutritive sweetener |
US4399163A (en) * | 1980-11-05 | 1983-08-16 | Pfizer Inc. | Branched amides of L-aspartyl-D-amino acid dipeptides |
US4411925A (en) * | 1980-01-21 | 1983-10-25 | Pfizer Inc. | Branched amides of L-aspartyl-d-amino acid dipeptides |
US4423029A (en) * | 1981-06-25 | 1983-12-27 | The Procter & Gamble Company | (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners |
US4786518A (en) * | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Iron mineral supplements |
US4789510A (en) * | 1986-06-03 | 1988-12-06 | Ube Industries, Ltd. | Process for producing a shaped, sintered magnesia article having an enhanced resistance to hydration and an improved mechanical strength |
US4822847A (en) * | 1986-01-27 | 1989-04-18 | Exxon Research And Engineering Company | Method of increasing viscosity of an aqueous solution with a sulfo betaine polymer |
US5151291A (en) * | 1985-12-27 | 1992-09-29 | Nisshin Flour Milling Co., Ltd. | Glycerides of eicosapentaenoic acid, processes for preparing the same and oil and fat products containing the same |
US5431940A (en) * | 1994-02-24 | 1995-07-11 | The Procter & Gamble Company | Preparation of noncarbonated beverage products with improved microbial stability |
US6126980A (en) * | 1995-02-28 | 2000-10-03 | The Procter & Gamble Company | Noncarbonated beverage products having superior microbial stability and process for preparing same |
US6235331B1 (en) * | 1999-07-29 | 2001-05-22 | Nisshin Flour Milling Co Ltd | Modified fish oil type material containing highly unsaturated fatty acid and/or esters thereof, and a composition containing said material |
US6326040B1 (en) * | 1999-03-08 | 2001-12-04 | The Procter & Gamble Co. | Beverage products having superior vitamin stability |
US20030044504A1 (en) * | 2001-03-26 | 2003-03-06 | Kao Corporation | Packaged emulsified beverage |
US20050129830A1 (en) * | 2002-08-07 | 2005-06-16 | Kao Corporation | Oil or fat composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3722540A1 (en) * | 1987-07-08 | 1989-01-19 | Fresenius Ag | FAT EMULSION, METHOD FOR THEIR PRODUCTION AND THEIR USE |
KR100343664B1 (en) * | 1993-12-20 | 2002-11-27 | 산에이겐 에후.에후. 아이. 가부시키가이샤 | Stable Emulsified Composition and Food Containing it |
NO313076B1 (en) * | 1999-12-28 | 2002-08-12 | Pronova Biocare As | Liquid nutrients and / or nutrients and processes for their preparation |
DE10013156A1 (en) * | 2000-03-17 | 2001-09-20 | Volkhard Jenning | Water-containing vehicle for cosmetic or dermatological compositions, in which active agents or auxiliaries are stabilized by combination of ascorbic acid or derivative, polyphenol and buffer |
CN1236683C (en) * | 2000-08-08 | 2006-01-18 | 花王株式会社 | oil/fat composition |
US7393552B2 (en) * | 2002-04-24 | 2008-07-01 | The Procter & Gamble Company | Compositions comprising protein and fatty acid |
WO2003094625A1 (en) * | 2002-05-08 | 2003-11-20 | Danmarks Tekniske Uni Technica | A facile two-step enzyme process for increasing the content of polyunsaturated fatty acids in fish oil |
US20060165735A1 (en) * | 2002-06-18 | 2006-07-27 | Abril Jesus R | Stable emulsions of oils in aqueous solutions and methods for producing same |
DE20220081U1 (en) * | 2002-12-23 | 2003-04-30 | Unilever N.V., Rotterdam | Edible emulsion that contains highly unsaturated fats |
KR20050007718A (en) * | 2003-07-11 | 2005-01-21 | 네오메가(주) | A composition containing docosahexaenoic acid |
US7118688B2 (en) * | 2004-02-23 | 2006-10-10 | The Texas A&M University System | Antioxidant compositions and methods of use thereof |
CA2656028A1 (en) * | 2006-06-23 | 2007-12-27 | The Procter & Gamble Company | Concentrated omega-3 fatty acids and mixtures containing them |
-
2007
- 2007-06-22 CA CA002656028A patent/CA2656028A1/en not_active Abandoned
- 2007-06-22 CN CNA2007800236775A patent/CN101478890A/en active Pending
- 2007-06-22 WO PCT/US2007/014774 patent/WO2007149591A2/en active Application Filing
- 2007-06-22 US US11/821,253 patent/US20070298083A1/en not_active Abandoned
- 2007-06-22 EP EP07796445A patent/EP2031982A2/en not_active Withdrawn
- 2007-06-22 BR BRPI0713264-6A patent/BRPI0713264A2/en not_active IP Right Cessation
- 2007-06-22 US US11/821,201 patent/US20070299133A1/en not_active Abandoned
- 2007-06-22 CN CNA200780023607XA patent/CN101478889A/en active Pending
- 2007-06-22 BR BRPI0713705-2A patent/BRPI0713705A2/en not_active IP Right Cessation
- 2007-06-22 WO PCT/US2007/014773 patent/WO2007149590A2/en active Application Filing
- 2007-06-22 CN CNA2007800232153A patent/CN101472490A/en active Pending
- 2007-06-22 CA CA002655985A patent/CA2655985A1/en not_active Abandoned
- 2007-06-22 US US11/821,226 patent/US20070298156A1/en not_active Abandoned
- 2007-06-22 CA CA002655769A patent/CA2655769A1/en not_active Abandoned
- 2007-06-22 WO PCT/US2007/014775 patent/WO2007149592A2/en active Application Filing
- 2007-06-22 BR BRPI0713034-1A patent/BRPI0713034A2/en not_active IP Right Cessation
- 2007-06-22 EP EP07796446A patent/EP2031983A2/en not_active Withdrawn
- 2007-06-22 EP EP07809884A patent/EP2031985A2/en not_active Withdrawn
-
2010
- 2010-01-04 US US12/651,641 patent/US20100104730A1/en not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338346A (en) * | 1978-12-21 | 1982-07-06 | The Procter & Gamble Company | Non-nutritive sweetener |
US4411925A (en) * | 1980-01-21 | 1983-10-25 | Pfizer Inc. | Branched amides of L-aspartyl-d-amino acid dipeptides |
US4399163A (en) * | 1980-11-05 | 1983-08-16 | Pfizer Inc. | Branched amides of L-aspartyl-D-amino acid dipeptides |
US4423029A (en) * | 1981-06-25 | 1983-12-27 | The Procter & Gamble Company | (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners |
US5151291A (en) * | 1985-12-27 | 1992-09-29 | Nisshin Flour Milling Co., Ltd. | Glycerides of eicosapentaenoic acid, processes for preparing the same and oil and fat products containing the same |
US4822847A (en) * | 1986-01-27 | 1989-04-18 | Exxon Research And Engineering Company | Method of increasing viscosity of an aqueous solution with a sulfo betaine polymer |
US4789510A (en) * | 1986-06-03 | 1988-12-06 | Ube Industries, Ltd. | Process for producing a shaped, sintered magnesia article having an enhanced resistance to hydration and an improved mechanical strength |
US4786518A (en) * | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Iron mineral supplements |
US5431940A (en) * | 1994-02-24 | 1995-07-11 | The Procter & Gamble Company | Preparation of noncarbonated beverage products with improved microbial stability |
US6126980A (en) * | 1995-02-28 | 2000-10-03 | The Procter & Gamble Company | Noncarbonated beverage products having superior microbial stability and process for preparing same |
US6326040B1 (en) * | 1999-03-08 | 2001-12-04 | The Procter & Gamble Co. | Beverage products having superior vitamin stability |
US6235331B1 (en) * | 1999-07-29 | 2001-05-22 | Nisshin Flour Milling Co Ltd | Modified fish oil type material containing highly unsaturated fatty acid and/or esters thereof, and a composition containing said material |
US20030044504A1 (en) * | 2001-03-26 | 2003-03-06 | Kao Corporation | Packaged emulsified beverage |
US20050129830A1 (en) * | 2002-08-07 | 2005-06-16 | Kao Corporation | Oil or fat composition |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8765661B2 (en) | 2008-03-20 | 2014-07-01 | Virun, Inc. | Compositions containing non-polar compounds |
US9788564B2 (en) | 2008-03-20 | 2017-10-17 | Virun, Inc. | Compositions containing non-polar compounds |
US20120093998A1 (en) * | 2009-02-11 | 2012-04-19 | Karl Manfred Voelker | High concentrated pufa emulsions |
US8603557B2 (en) | 2009-09-11 | 2013-12-10 | Kraft Foods Group Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable concentrated liquids |
US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
US20120269930A1 (en) * | 2009-11-10 | 2012-10-25 | Cognis Ip Management Gmbh | Composition comprising a lipid suitable for human consumption |
US20120308711A1 (en) * | 2010-02-06 | 2012-12-06 | Cognis Ip Management Gmbh | Drink |
US9320295B2 (en) | 2010-03-23 | 2016-04-26 | Virun, Inc. | Compositions containing non-polar compounds |
CN101843571B (en) * | 2010-04-16 | 2012-11-07 | 苏州纳康生物科技有限公司 | Multiple emulsion for loading tea polyphenol and preparation method thereof |
CN101843571A (en) * | 2010-04-16 | 2010-09-29 | 苏州纳康生物科技有限公司 | Multiple emulsion for loading tea polyphenol and preparation method thereof |
US10335385B2 (en) | 2010-06-21 | 2019-07-02 | Virun, Inc. | Composition containing non-polar compounds |
US8741373B2 (en) | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
WO2012003515A3 (en) * | 2010-07-02 | 2012-07-05 | Eric Hauser Kuhrts | Stable fatty acid-containing formulations |
US8722131B2 (en) | 2010-09-07 | 2014-05-13 | Dsm Nutritional Products Ag | Comestible emulsions |
US20150004282A1 (en) * | 2012-01-09 | 2015-01-01 | Pacific Shore Holdings, Inc. | Dietary supplements containing caffeine and niacin |
WO2013120025A1 (en) | 2012-02-10 | 2013-08-15 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US10874122B2 (en) | 2012-02-10 | 2020-12-29 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US10687547B2 (en) | 2012-02-15 | 2020-06-23 | Kraft Foods Group Brands Llc | Compositions and methods for inhibiting precipitation of dyes in a beverage |
US12342839B2 (en) | 2012-02-15 | 2025-07-01 | Kraft Foods Group Brands Llc | Compositions and methods for inhibiting precipitation of dyes in a beverage |
US11737480B2 (en) | 2012-02-15 | 2023-08-29 | Kraft Foods Group Brands Llc | Compositions and methods for inhibiting precipitation of dyes in a beverage |
US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
KR101842988B1 (en) * | 2012-11-02 | 2018-03-28 | 프로노바 바이오파마 노르지 에이에스 | Removal of undesired components from oil compositions |
KR102091463B1 (en) * | 2012-11-02 | 2020-03-23 | 프로노바 바이오파마 노르지 에이에스 | Method for removing undesired components from oil compositions |
KR20180034686A (en) * | 2012-11-02 | 2018-04-04 | 프로노바 바이오파마 노르지 에이에스 | Removal of undesired components from oil compositions |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
US10285971B2 (en) | 2014-09-18 | 2019-05-14 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US20210161165A1 (en) * | 2017-09-01 | 2021-06-03 | Fuji Oil Holdings Inc. | Oil and fat composition containing unsaturated fatty acid |
FR3148036A1 (en) * | 2023-04-24 | 2024-10-25 | Polaris | Composition of oil enriched with polyunsaturated fatty acids |
WO2024223681A1 (en) | 2023-04-24 | 2024-10-31 | Polaris | Polyunsaturated fatty acid-enriched oil composition |
Also Published As
Publication number | Publication date |
---|---|
WO2007149591A2 (en) | 2007-12-27 |
EP2031982A2 (en) | 2009-03-11 |
CA2655769A1 (en) | 2007-12-27 |
CA2656028A1 (en) | 2007-12-27 |
CN101472490A (en) | 2009-07-01 |
WO2007149592A2 (en) | 2007-12-27 |
CN101478889A (en) | 2009-07-08 |
US20070298156A1 (en) | 2007-12-27 |
WO2007149590A3 (en) | 2008-03-20 |
EP2031985A2 (en) | 2009-03-11 |
BRPI0713264A2 (en) | 2012-04-17 |
EP2031983A2 (en) | 2009-03-11 |
BRPI0713705A2 (en) | 2012-10-30 |
BRPI0713034A2 (en) | 2012-07-17 |
WO2007149592A3 (en) | 2008-02-28 |
CA2655985A1 (en) | 2007-12-27 |
US20100104730A1 (en) | 2010-04-29 |
WO2007149591A3 (en) | 2008-02-21 |
US20070299133A1 (en) | 2007-12-27 |
CN101478890A (en) | 2009-07-08 |
WO2007149590A2 (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070298083A1 (en) | Concentrated omega-3 fatty acids and mixtures containing them | |
US20100166915A1 (en) | Carbonated beverage containing polyunsaturated fatty acids | |
AU2005263018A1 (en) | Powdered compositions containing an edible oil and their use in food products | |
ES2312766T3 (en) | COMPOSITIONS THAT INCLUDE CDONCENTRATE PROTEIN LACTEA AND FATTY ACID AND PROCEDURES FOR PREPARATION. | |
ES2354276T3 (en) | EDIBLE EMULSIONS. | |
JP3542054B2 (en) | Antioxidants for docosahexaenoic acids | |
EP3446572A1 (en) | Separated liquid seasoning | |
AU2013265072A1 (en) | Emulsion comprising polyunsaturated fatty acids | |
US6428461B1 (en) | Method for inhibiting oxidation of polyunsaturated lipids | |
EP1945049B1 (en) | Packaged oxidation-stable oil-in-water emulsion | |
Jacobsen et al. | Antioxidative strategies to minimize oxidation in formulated food systems containing fish oils and omega‐3 fatty acids | |
EP2055199B1 (en) | Dressing composition | |
JPH03297364A (en) | Powdery composition for preventing thrombosis | |
KR20190003559A (en) | Method of manufacturing nutritional formula | |
US11297863B2 (en) | Emulsified seasoning | |
JP2009225724A (en) | Composition containing arachidonic acid | |
JP2018038293A (en) | Emulsified composition of highly unsaturated fatty acid-containing fats and oils | |
RU2777978C2 (en) | Methods for manufacturing nutritional compositions | |
JP5217232B2 (en) | α-Lipoic acid-containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PROCTER & GAMBLE COMPANY, THE, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MEHANSHO, HAILE (NMN);LUHADIYA, ASHOK PREMCHAND;MILLER, LARRY EUGENE;AND OTHERS;REEL/FRAME:019635/0803;SIGNING DATES FROM 20070627 TO 20070719 Owner name: PROCTER & GAMBLE COMPANY, THE, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MEHANSHO, HAILE (NMN);LUHADIYA, ASHOK PREMCHAND;MILLER, LARRY EUGENE;AND OTHERS;SIGNING DATES FROM 20070627 TO 20070719;REEL/FRAME:019635/0803 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |